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Production of fuel, pharmaceuticals, and polymers by immobilized enzymes is one of 
the attractive research interests in the biocatalysis field due to the enhanced stability as 
well as recyclability of immobilized enzymes. Over the last few decades, various 
immobilization carriers and techniques have been established. Lately, magnetic 
nanoparticles (MNPs) have received an increasing attention because of the simplicity of 
functionalizing their surface, high surface area per volume, great dispersibility and easy 
separation and recovery using magnet. However, prepurification of the target enzyme 
before immobilization is essential for most of enzyme immobilization techniques. The 
costly and low-yielding purification steps often complicate the preparation of 
nanobiocatalysts and increase their cost. In this thesis, the preparation of active and 
recyclable magnetic nanobiocatalysts via simultaneous purification and immobilization 
of His-tagged enzymes on the MNPs is studied and the nanobiocatalysts are used for 
production of biodiesel, pharmaceuticals and polyesters. 
First, the iron oxide nanoparticles with a poly(glycidyl methacrylate) shell were 
synthesized to obtain core-shell structured magnetic nanoparticles and further 
functionalized with long-armed nickel-nitrilotriacetic acid  (Ni-NTA) functions. These 
MNPs were utilized to simultaneously purify and immobilize the extracellular His-
tagged Thermomyces lanuginosus lipase (His-TLL) directly from cell culture 
supernatant of the recombinant P. pastoris (h-TLL). The immobilization was optimized 
to achieve high enzyme loading efficiency and full activity recovery. This magnetic 
nanobiocatalyst was successfully used to convert waste grease with methanol to 
xiv 
biodiesel, affording high (fatty acid methyl esters) FAME yield (94%) and excellent 
recyclability when reused for seven cycles. Moreover, the Ni-NTA-MNPs were 
regenerable from the recycled nanobiocatalyst. The generality of this method was also 
confirmed by immobilizing His-tagged Candida antarctica lipase B from cell culture 
supernatant for the esterification of waste grease.  
Second, the first time immobilization of O-acetylserine sulfhydrylase (OASS) CysK 
and CysM was conducted from cell free extract of recombinant E. coli (CysK) E. coli 
(CysM) with Ni-NTA-MNPs via His-tag affinity bonding, affording up to 190 mg 
enz./g MNPs. These nanobiocatalysts were used to synthesize β-pyrazol-1-yl-alanine 
from pyrazole and O-acetylserine (OAS). The biotransformation was optimized and 
catalytic performance of both nanobiocatalysts was compared, which CysK showed 
higher activity for this reaction. The fast biotransformations and good recyclability with 
nanobiocatalysts were achieved.  
Third, the substrate specificity of the OASS CysM was explored to synthesize a group 
of unnatural amino acids. The free and immobilized His-CysM on the cobalt-NTA-
MNPs or Ni-NTA-MNPs catalyzed the biotransformations and the nanobiocatalysts 
almost replicated the activity of the free enzyme (92–100%) in the synthesis of S-
arylcysteines from various arylthiols and OAS. The chemo- and regioselectivity of 
CysM towards substituted thiophenols was observed and studied. Also, the recyclability 
of both nanobiocatalysts was excellent, retaining 80–95% productivity in the fifth cycle.  
Fourth, immobilized His-TLL was used to catalyze ring-opening polymerization (ROP) 
of various cyclic monomers to present a new application of magnetic nanobiocatalysts. 
xv 
The activity of the immobilized His-TLL for the ROP of these monomers was 
successfully examined for the first time. The reaction kinetics of the ROP of ε-
caprolactone and δ-valerolactone by this nanobiocatalyst was also studied and 
compared to some reported enzymatic ROP by different enzymes. The high activity of 
the developed nanobiocatalyst was promising.   
xvi 
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Chapter 1 Introduction 
This chapter presents the research background, motivations and objectives followed by 
thesis outline.  
1.1 Biocatalysis for chemical synthesis 
Biocatalysis is a process that the natural catalysts (biocatalysts) are used to convert the 
organic compounds to the desired product.
[1,2]
 Nowadays, biocatalysis attracts much 
attention for the synthesis of chemicals and offers a great alternative for the traditional 
organic synthesis methods. Biocatalysis can be performed in mild reaction conditions 
offering high selectivity and atom efficiency with less by-products and waste,
[3]
 thus, it 
is an environmental friendly and a green tool. Furthermore, biocatalysts are able to 
perform considerable types of reactions. Consequently, the number of commercial 
chemical plants that use biocatalysts rather than conventional catalysts has significantly 
increased over the last few years.
[4-6]
 
1.2 Biotransformations for production of biodiesel, pharmaceuticals and 
polymers  
From the biotransformation point of view, enzymes are a powerful and green tool for 
sustainable production of several pharmaceutical intermediates, fuel and polymers.
[7-11]
 
There are many complex pharmaceutical intermediates including chiral compounds that 
are easy and clean to be synthesized by enzymatic approach instead of using toxic 
catalysts with many complicated synthesis and product purification steps. 
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The enzymatic production of fuels, especially biodiesel, attracted much attention in the 
last decade due to the high activity of lipases in converting oils from different sources 
to the biodiesel with clean processes.  
Enzymatic polymerization has also become a popular research field to prepare well-
defined polymers for different applications. More specifically, enzymatic synthesis of 
polyesters with biomedical applications such as poly(ε-caprolactone), which need to be 
free of toxic metals remnants, is of great interest. 
1.3 Different forms of biocatalysts  
Biocatalysts can be used in different forms including whole-cell, free or immobilized 
enzyme.
[6,12,13]
 Depending on the application, each of these three forms of biocatalyst 
can be used. However, the whole-cell systems often suffer from low mass transfer, low 
reaction rate and relatively unclean biotransformation compared to the free or 
immobilized enzymes. Although free enzyme can partially solve the low reaction rate 
of the whole-cell systems by considering the fact that free enzyme is a homogeneous 
biocatalyst in the commonly used aqueous phase, it still suffers from instability, high 
cost and difficulties in the recovery from reaction mixture. These major drawbacks are 
important hurdles for the practical applications of free enzymes.
[14,15]
 Immobilization of 
enzyme can address some of these problems. Immobilization often enhances the 
enzyme stability, allows biocatalyst separation from reaction mixture since it is a 





1.4 Immobilization of enzyme on a support 
Enzyme immobilization employing variety of solid supports with several different 
techniques for has been widely investigated in the last few decades. Synthetic organic 
and inorganic polymers, naturally occurring polymers, smart polymers, and 
nanocarriers such as magnetic nanoparticles were used for the immobilization of 
enzymes.
[18]
 In a more conventional way, materials with a flat or mesoporous structure 
were used. However, mass transfer limitation and low dispersibility of immobilized 
enzymes can hinder the applications of these materials. Therefore, nanocarriers were 
introduced to relief these issues. 
Moreover, most of the enzyme immobilization techniques require prepurification of the 
enzymes which is costly and low-yielding.
[19,20]
 Hence, it is of great interest to explore 
the more selective approaches. One immobilization approach that can simultaneously 
purify and immobilize the target enzyme from a pool of proteins is His-tag affinity 
immobilization. This approach has been mostly explored for the enzyme purification 
purposes but seldom for the preparation of the active immobilized enzymes as 
biocatalyst. Therefore, further research needs to be conducted to investigate the affinity 
immobilization more in-depth for preparation of active and recyclable biocatalysts.  
1.5 Nanobiocatalysts for biotransformations  
Nanocarriers have emerged as a solution and helped to greatly enhance the mass 
transfer and dispersibility of the immobilized enzyme and also to achieve high enzyme 




The obtained immobilized enzyme would be nano-sized and can be called 
nanobiocatalyst. 
For the convenient recovery of the nanobiocatalyst, one very simple approach is using 
magnetic nanoparticles, which can be recovered and reused by applying a magnet.
[23]
  
Nanobiocatalysis is a powerful way of performing many biotransformations.
[24]
 
However, this technology is in the early stage of development and in-depth research 
need to be conducted and there are many issues that need to be addressed to prepare 
robust nanobiocatalysts for practical applications. 
1.6 Objectives 
The overall objective of this thesis is to prepare active and recyclable magnetic 
nanobiocatalysts without prepurification of the target enzyme and by simple 
simultaneous purification and immobilization of His-tagged enzymes on the MNPs 
with appropriate surface functions and also studying their applications in the production 
of biodiesel, pharmaceuticals and polyesters through green and sustainable processes. 
The thesis objectives in more details are: 
 To prepare nanobiocatalsyt via simple and efficient simultaneous purification and 
immobilization of extracellular His-tagged TLL by Ni-NTA-MNPs to convert waste 
grease to biodiesel. The magnetic nanoparticles with an iron oxide core and a 
poly(glycidyl methacrylate) shell with a long-armed nickel-nitrilotriacetic acid 
functions were synthesized. The recombinant P. pastoris (h-TLL) was engineered 
to express extracellular His-TLL. The use of the functionalized magnetic 
5 
nanoparticles directly in the cell culture supernatant without cell disruption could 
provide simultaneous purification and immobilization of His-TLL on the Ni-NTA-
MNPs. The cell culture was scaled up using a bioreactor and immobilization 
procedure optimized for the efficient preparation of highly active magnetic 
nanobiocatalyst. This nanobiocatalyst was used for one-pot esterification and 
transesterification of the waste grease with high free fatty acid content to prepare 
biodiesel (fatty acid methyl esters) in a high yield. The nanobiocatalyst was 
recycled and reused successfully. Moreover, the magnetic nanoparticles from 
nanobiocatalyst were regenerated after recycling and then reused for immobilization. 
The extracellular His-CALB was used to demonstrate the generality of the method. 
The use of extracellular enzyme could further simplify the immobilization process 
and may pave the way for more efficient and economic preparation of the 
nanobiocatalysts. 
 To investigate the immobilization of His-tagged O-acetylserine sulfhydrylase CysK 
and CysM enzymes on the Ni-NTA-MNPs and the use of the immobilized enzymes 
as active and recyclable nanobiocatalysts for the synthesis of β-pyrazol-1-yl-alanine. 
Recombinant E. coli cells expressing His-tagged CysK or CysM were engineered. 
Employing simultaneous purification and immobilization method for the cell free 
extract of each His-tagged enzyme with Ni-NTA-MNPs provided active magnetic 
nanobiocatalysts. These nanobiocatalysts catalyzed the biotransformation of O-
acetylserine and pyrazole to β-pyrazol-1-yl-alanine as a useful pharmaceutical 
intermediate. The catalytic performance of the immobilized His-CysK and CysM 
was compared. In addition, the activity of the obtained nanobiocatalysts was 
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compared to the activity of the respective free enzymes. The recyclability of the 
prepared magnetic nanobiocatalysts was investigated and enhanced. The higher 
productivity of the developed nanobiocatalysts compared with the reported whole-
cell and free enzyme systems for the same biotransformation, is promising and this 
nanobiocatalyst can be used for other potential applications.  
 To explore the substrate specificity of the OASS CysM towards benzylthiol and 
several substituted arylthiols and for the synthesis of unnatural L-α-amino acids (S-
arylcysteines). The Co-NTA-MNPs were synthesized and used for the simultaneous 
purification and immobilization of His-tagged OASS CysM. The activity of the free 
and immobilized enzyme was investigated for these biotransformations and the 
chemo- and regioselectivity of the CysM towards substituted arylthiols were 
demonstrated. Moreover, the resulting S-arylcysteines were characterized. The 
catalytic performance of the immobilized His-CysM on the Ni-NTA-MNPs and Co-
NTA-MNPs was compared to the free enzyme. These nanobiocatalysts were 
successfully recycled and reused and their performance was compared. This method 
provides an efficient and green process for the synthesis of S-arylcysteines as useful 
or potentially useful pharmaceutical intermediates. 
 To study the application of the nanobiocatalysis for the enzymatic polymerization 
by using immobilized His-TLL on the Ni-NTA-MNPs for the ring-opening 
polymerization of cyclic monomers. The nanobiocatalyst, His-TLL-MNPs, was 
successfully used to catalyze ring-opening polymerization of the unsubstituted and 
substituted lactones in bulk or organic media and the obtained polyesters were 
further characterized. The monomer conversion rates and kinetics of the 
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polymerization of the ε-caprolactone and δ-valerolactone were studied to evaluate 
and compare the catalytic performance of the immobilized His-TLL with the other 
immobilized enzymes. Also, the oligomers from substituted lactones and D-lactide 
were prepared using His-TLL-MNPs.  
1.7 Thesis Outline  
This thesis includes seven chapters. Chapter 1 gives a brief background and 
introduction of the study as well as the objectives of this thesis. In Chapter 2, the 
extensive literature review is provided for the enzyme immobilization methods, 
reviewing immobilization supports, synthesis and properties of MNPs and their 
application for enzyme immobilization and comprehensive background of used 
enzymes and synthesized products in this thesis. Chapter 3 deals with the simple and 
efficient method of simultaneous purification and immobilization of the extracellular 
His-tagged enzymes on the Ni-NTA-MNPs and their application for the biodiesel 
production from waste grease. In Chapter 4, the immobilization of His-tagged CysK 
and CysM is presented to synthesize PAA in a more productive process. Chapter 5 
reports the production of the unnatural amino acids (S-arylcysteines) with free and 
immobilized His-CysM and investigates the substrate specificity of this enzyme for the 
substituted arylthiols. Chapter 6 includes a novel application of the nanobiocatalysis by 
performing enzymatic ring-opening polymerization using immobilized His-tagged TLL 
on the MNPs. Chapter 7 concludes the thesis findings with recommendations for the 
future studies.  
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Chapter 2 Literature Review 
This chapter reports a comprehensive review of the literature in the field. 
2.1 Enzyme Immobilization 
Enzymes are catalyst that can be found in the nature and are able to catalyze reactions 
in mild temperature, pressure and pH. They also show unique enantio-, chemo-, and 
regioselectivity towards certain substrates.
[25-29]
 Therefore, most of the conventionally 
complex processes can be conducted by enzymes through straightforward reaction 
routes, giving less waste, saving energy and providing green and sustainable processes. 
As it can be seen in Figure ‎2.1, the number of commercial processes that performed by 
enzymatic biotransformations has grown significantly in recent years.   
 
Figure ‎2.1. The total number of biotransformation processes with an industrial scale. 
(Reprinted with permission, Copyright © 2002, Elsevier)[4] 
This is a driving force to enhance the enzymatic catalysis systems to establish a more 
attractive platform for its practical applications.
[30]
 The recent advances in 
biotechnology and more specifically protein engineering could provide enzymes with 
9 




The selection of a suitable biocatalyst form that can be used in a plant may require 
considering several points such as reactor design,
[18]
 reaction type (e.g. oxidation), the 
target enzyme and the final product price.
[11]
 Whole-cell systems as free or immobilized 
cells can be considered for conducting some reactions. However, the mass transfer 
limitation for both systems, specifically for immobilized cells, is the main concern. For 
the free enzyme as biocatalyst, the purified enzyme preparation cost, instability and 
lack of recyclability are the major issues that need to consider. Additionally, the 
recovery of the final product to avoid its contamination by protein especially in the 
pharmaceutical industry can increase the downstream processing cost.  
Enzyme immobilization addresses these issues by stabilizing enzyme after 
immobilization and in some cases enhances the activity or selectivity of the 
enzyme.
[35,36]
 It is also a solution for the product recovery by possibly easier separation 
due to the fact of being heterogeneous biocatalyst. Immobilization of enzymes can help 
to decrease the biocatalyst cost by recycling and reuse of it. In fact, the biocatalyst 





biocatalyst to product ratio have been reported only for the immobilized biocatalysts.
[11]
 
Therefore, the use of immobilized enzyme is a dominant trend for the practical 
applications of the biocatalysis.
[14,37]
 In Table ‎2.1, some of the immobilized enzymes 




Table ‎2.1. Some of the reported industrial applications for immobilized enzyme systems. 
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2.2 Enzyme immobilization techniques   
The most frequent techniques of enzyme immobilization can be divided into two main 
categories of irreversible and reversible immobilization methods.
[39-41]
 A detailed 
description of these two categories and their schemes, in Figure ‎2.2, are given below.  
2.2.1 Irreversible immobilization  
In this technique, enzyme attaches on the carrier permanently and avoids enzyme 
leakage during the reaction. However, after decreasing the enzyme activity, it is not 
possible to detach the enzyme from the support unless we damage the support or 
biological structure of the enzyme. 
2.2.1.1 Covalent bonding  
In this method a covalent bond forms between enzyme and support.
[42,43]
 The support 
usually contains reactive chemical groups (e.g. amide) and if the reactive groups were 
absent, it would be activated to be utilized for immobilization. This method prevents 
enzyme leakage. However, the covalent bond can disturb the amino acid residues of the 
enzyme; thus, the enzyme activity will drop after immobilization.
[41]
 
2.2.1.2 Entrapment and encapsulation 
This technique can be acquired from occlusion of enzyme in a polymeric network.
[44,45]
 
Different methods such as gel, fiber and micro-encapsulation can be used to entrap the 
enzymes. The major limitation of this approach is the low mass transfer through the 
support.  
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2.2.1.3 Cross-linking of Enzymes 
Cross-linked enzymes can be prepared via reaction of the amine group on the enzyme’s 
surface with a bifunctional group (e.g. glutaraldehyde). Cross-linked enzyme crystals
[46]
 
and cross-linked enzymes aggregates
[47-49]
 are classified within this category. In fact, 
this technique is carrier-free. Nonetheless, this approach suffers from low activity 
retention and mechanical instability.
[50]
  
2.2.2 Reversible immobilization 
Reversible immobilization allows recovering the support after enzyme deactivation 
without destroying the support. The following methods are the most frequently used 
approaches that can be classified in this category. 
2.2.2.1 Adsorption 
The nonspecific adsorption of enzyme onto the support can be conducted using 
different forms of physical adsorption such as hydrogen bonding, van der Waals forces 
and hydrophobic interactions. This technique might be the simplest among the 
immobilization techniques. For instance, some enzymes (e.g. lipases)
[51]
 can be simply 
immobilized on the hydrophobic resins benefiting from hydrophobic interactions 
between the enzyme and the support. It can provide high enzyme activity retention 
while the enzyme leakage is the main defect of this method. 
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2.2.2.2 Ionic bonding 
A simple approach for the reversible immobilization of enzymes is ionic bonding, 
which enzymes are bonded through salt linkages. Generally, in this method it is not 
easy to find a condition that the enzyme remains strongly bonded and highly active, 
simultaneously.
[52]
 In addition, it is problematic when a highly charged support is 
utilized in presence of charged substrate or product. Moreover, this approach suffers 
from enzyme leakage. 
2.2.2.3 Metal-chelate affinity 






 have been attached 
by chelating agent to the support.
[19,52,53]
 This chelating agent (e.g., NTA, iminodiacetic 
acid) helps to confine the metal ion on the carrier and provides a stronger bonding than 
the direct attachment of the metal ions to the carrier surface, which often suffers from 
the metal leakage. Therefore, the desired metal-chelate can be introduced on the surface 
of the support and then it can be used to coordinate selectively with His-tagged 
enzymes in a protein pool. This approach is promising and shows many advantages 
such as being easy to engineer His-tagged enzyme and extremely high affinity between 
His-tagged enzyme and metal ion.
[54]
 In addition, in this method enzyme activity and 
conformation can be retained after immobilization and enzyme leakage is low due to 
the small dissociation constant between the metal ion and His-tagged enzyme. The 
selective coordination of His-tagged enzymes enables to simultaneously purify and 
immobilize the target enzyme.  
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Figure ‎2.2. Demonstration of the different enzyme immobilization techniques for two major 
irreversible and reversible methods.  
After evaluating all of the immobilization techniques, the metal-chelate affinity enzyme 
immobilization is more attractive for further studies due to its clear advantages. 
Therefore, among all aforementioned immobilization methods, we want to explore 
metal-chelate affinity and investigate the activity and recyclability of the obtained 
immobilized enzymes.  
2.3 Supports for enzyme immobilization 
Even though the enzyme immobilization is getting to be a mature technology, there are 
no clear rules for identifying and selection of the best support for a certain 
application.
[54]
 In Table ‎2.2, a list of carriers that have been reported for the enzyme 




Table ‎2.2. Various supports used for the enzyme immobilization. (Partially reprinted with 
permission. Copyright © 2013 Humana Press Inc., Totowa, NJ)[55] 
Organic 
Natural polymers  
•‎Polysaccharides:‎cellulose,‎dextrans,‎agar,‎agarose,‎chitin, chitosan, alginate 
•‎Proteins:‎collagen,‎albumin 
•‎Carbon 
Synthetic polymers  
•‎Polystyrene 
•‎Other‎polymers:‎polyacrylate,‎polymethacrylates,‎polyacrylamide,‎polyamides,‎
vinyl and allyl-polymers 
Inorganic 
Natural minerals  
Bentonite, silica 
Processed materials  
Glass (non-porous and controlled pore), metals, controlled pore metal oxides, 




Stabilized by organics coating 
diols, long-chain fatty acids, alkyl amines 
Stabilized by inorganics coating 
polypyrrole,  poly(glycidyl methacrylate), poly(N-vinyl-2-pyrrolidone),  




poly-N-isopropylacrylamide, poly(acrylic acid-co-acrylamide)  
2.3.1 Organic polymers 
Conventionally used organic polymers as immobilization support had a small ratio of 
surface area to volume, resulting low enzyme loadings on the carriers. This means large 
amount of immobilized biocatalyst (support + enzyme) should be loaded to perform the 
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reaction. The mesoporous or macroporous materials were introduced to overcome the 
low enzyme loading issue.
[57]
 However, these materials face with mass transfer 
limitations since the substrate molecules have a limited access to the immobilized 
enzyme. There are several reported examples of this class of supports for the enzyme 
immobilization. Lewatit VP OC 1600 made from poly(methyl methacrylate-co-
divinylbenzene) is a well-known matrix, which is commercially used to immobilize 
Candida antarctica lipase B, Novozym 435, through the adsorption.
[51,58]
 Another 
widely investigated macroporous polymeric carrier is Eupergit
®
 C, which is used for 
enzyme immobilization via covalent bonding.
[59]
  
2.3.2 Natural polymers 
Several types of naturally occurring polymers and proteins have also been reported as 
immobilization carrier. Chitosan and chitin are polyaminosaccharides that were used to 
immobilize several enzymes. β-amylase (EC 3.2.1.2), alcohol oxidase (EC 1.1.3.13), 
alanine dehydrogenase (EC 1.4.1.1) were immobilized on the chitosan beads and 
isoamylase (EC 3.2.1.68) and β-galactosidase (EC 3.2.1.23) ) on the chitin powder.[38] 
A cellulose based carrier, which is modified with diethylaminoethyl function, is also 
commercialized. It was used to immobilize aminoacylase from Aspergillus oryzae for 
production of L-amino acids by resolution of racemic DL-amino acids.
[60]
 As another 
example, Ni-NTA agarose beads are commercially available from QIAGEN
®
 or other 
companies. However, these agarose beads are used for protein purification purposes 
and generally considered as soft support and unsuitable for the catalysis applications. 
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2.3.3 Inorganic polymers 
Several inorganic carriers are employed to immobilize different enzymes. Among them, 
zeolite, mesoporous glass sole-gel,
[43]
 silica and mesoporous silica were widely 
investigated. Zeolite in the form of MCM-41 was used to immobilize enzymes.
[61]
 An 
epoxide hydrolase from Aspergillus niger (E.C. 3.3.2.3) was immobilized on the silica 
gel showing with a similar activity to the free enzyme.
[42]
 However, the most widely 
used inorganic carrier is the mesoporous silica considering the large number of reported 
articles using this type of materials.
[57]
 Several class of enzyme such as oxidoreductases, 




2.3.4 Smart polymers 
Stimuli-responsive polymers or smart polymers can respond to the changes in their 
environment such as pH, ionic strength or temperature.
[62,63]
 There are few reports on 
using thermo-responsive materials for enzyme immobilization. Poly-N-
isopropylacrylamide is a thermo-responsive polymer, which is reported for the enzyme 
immobilization. This polymer precipitates above its critical solution temperature; 
therefore can be separated from the reaction mixture. For instance, penicillin G acylase 
was immobilized on poly-N-isopropylacrylamide to prepare cephalexin.
[64]
 More 
recently, Mackenzie and Francis
[65]
 used Poly-N-isopropylacrylamide to immobilize 
endoglucanase for hydrolysis of the cellulosic substrate. However the recyclability was 
poor affording 3 cycles with 60% productivity retention at last cycle. In the other work, 
Wu et al.,
[66]
 demonstrated immobilization of hemoglobin or horseradish peroxidase on 
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porous microgels of Poly-N-isopropylacrylamide. The other type of thermo-responsive 
polymers can be synthesized with an upper critical solution temperature. It means this 
type of polymers can be separated below their critical temperatures and this property 




The conventional enzyme immobilization as it was described above, suffered from low 
enzyme loading capacity of the non-porous materials, and mass transfer limitation in 
the porous materials. Thus, nanotechnology could deliver solutions to address these 
issues.
[22]
 Nanoparticles depending on their size have a very high surface area per 
volume ratio. This aids to increase the enzyme loading per gram of catalyst. In addition 
the high amount of immobilized enzyme is readily available on the particle’s surface 
and the nano-sized particles can mimick the homogeneous catalysis; thus, it can 
enhance  the mass transfer.
[56]
  
The immobilization of the enzymes on the MNPs has become an attractive research 
interest, covering numerous reports in the literature.
[21,24,68]
 Shan et al., reported 
immobilization of the glucose oxidase on the calcium carbonate nanoparticles.
[69]
 Other 
groups reported gold or silver nanoparticles for enzyme immobilization.
[70,71]
 However, 
these immobilized enzymes on the nanoparticles are reported for biosensor preparation 
and its applications. If gold or silver nanoparticles were used a carriers to prepare 
biocatalysts, their separation and recovery from reaction mixture would need very high 
speed centrifugation. Also, considering the high price of gold or silver nanoparticles, 
these are unsuitable immobilization carriers. 
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To solve this issue, the magnetic nanoparticles (MNPs) were introduced and studying 
their applications in biocatalysis received an increasing attention in the last decade.
[18,24]
 
2.3.6 Magnetic nanoparticles  
MNPs possess the general properties of the nano-sized material such as high 
dispersibility and surface area; they also provide a facile separation by external 





 and magnetic resonance imaging.
[75]
 
MNPs can be designed and synthesized in the various morphologies. In Figure ‎2.3, 
several possibilities are illustrated. The most commonly used MNPs for catalysis and 
biocatalysis are those with a spherical or core-shell‎morphology‎ (see‎ “a”‎ and‎ “c”‎ in‎
Figure ‎2.3). 
 
Figure ‎2.3. Various morphologies of MNPs: a) simple spherical MNPs, b) bimetallic MNPs, c) 
core–shell MNPs, d) core–shell particles with multinuclei MNPs, e) MNP-silica 
nanocomposites, f) silica spheres with MNPs on their surface, g) encapsulated mesoporous with 
MNPs. (Reprinted with permission. Copyright © 2010 Wiley-VCH Verlag GmbH & Co. KGaA, 
Weinheim)[56] 
20 
2.3.7 Synthesis of MNPs 
There are several possible ways to synthesize the MNPs including co-precipitation, 
thermal decomposition, hydrothermal, sol-gel and microemulsion.
[76]
 By employing 
these methods, several types of MNPs can be synthesized. Variety of MNPs was 
reported in different forms as metals (e.g., Fe or Ni), iron oxides (e.g., Fe3O4), alloys 
(e.g., FePt) and ferrites (e.g., CoFe2O4). These MNPs could have been used directly or 
as a matrix for further modifications for catalysis purposes. Among them, magnetite 
(Fe3O4) became a favored choice because of the simplicity of its synthesis as well as the 
cheap price. 
2.3.8 Stabilizing of MNPs  
While MNPs offer unique properties, their long term instability is a major concern. 
Pure metals or iron oxides are very sensitive to air exposure and can be easily oxidized. 
Thus, a protection or stabilization method is essential in the synthesis of almost all of 
the MNPs.
[77]
 Several techniques are developed to further protect the MNPs. These 
coating approaches can be categorized into two main types of organic coating and 
inorganic coating.  
2.3.8.1 Organic coating  
Organic polymers and surfactants are popular materials for the coating of the MNPs. 
Several polymer coatings including natural and synthetic polymers were reported to 




 were reported as 







 and poly(vinyl alcohol)
[74]
 were also reported for the 
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coating of MNPs. Although these polymeric materials can stabilize the MNPs, they 
negatively affect the magnetic properties of the MNPs.  
Oleic acid is another good example of the organic materials, which is considered as one 
of the best stabilizers for the iron oxide MNPs.
[84,85]
 
Carbon coating was also successfully used for MNPs protection and gave a very high 
chemical and thermal stability.
[86]
 In addition, it could enhance the magnetic properties 
due to the metallic state of the coated particles.
[76]
 Nikitenko et al., reported the air-
stable cobalt MNPs with a carbon coating via sonico-chemical approach.
[87]
  
2.3.8.2 Inorganic coating 
Silica is an inorganic material that was widely used to stabilize the iron oxide MNPs.
[88]
 
It helped to protect the iron oxide shell from unwanted interactions and provided a 
remarkably high stability even at high temperatures. 
Metals with low reactivity such as gold or platinum are also reported to protect the iron 
oxide core from oxidation.
[89,90]
 
2.3.9 Functionalization of MNPs 
Surface group functions play a crucial role in designing MNPs with desired properties 
such as hydrophilicity or hydrophobicity, surface charge and MNPs interactions with 
different reagents.
[74]
 MNPs are generally easy to functionalize, especially after coating 
with an appropriate material. Attachment of new surface functions and ligands to the 
existent reactive functions of the coating materials would be strait forward. This means 
the engineering and designing of the MNPs for many special applications is convenient. 
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For the enzyme immobilization purposes, functionalization of the MNPs highly 
depends on the immobilization method. For instance, for covalent bonding approach, 
there is a need to introduce a reactive function (e.g. glutaraldehyde) to react with the 
available surface functions of the enzyme such as N─H2. 
2.4 Magnetic nanobiocatalysts and their application 
Nanobiocatalyst‎refers‎to‎biocatalyst‎in‎the‎“nano”‎size.‎Some‎researchers‎believe‎nano-
sized materials have‎a‎less‎than‎10‎nm‎size,‎whereas‎in‎the‎biocatalysis‎field,‎the‎“nano”‎
size can be extended to the range of 100 nm since the enzyme itself has a size of 4–10 
nm. Applying MNPs for the enzyme immobilization provides rapid reaction rates due 
to the low mass transfer limitations, high enzyme loading on the carrier and facile 
separation and reuse of the magnetic nanobiocatalyst, which is vital since enzymes are 
usually rare and expensive.
[21,68,91,92]
 
Similar to the other immobilization supports, irreversible and reversible immobilization 
methods were applied to the various types of MNPs to prepare magnetic 
nanobiocatalysts. In the following sections, these approaches are reviewed as well as 
the target biotransformations and their products are analyzed from the reported 
literature. 
2.4.1 Irreversible enzyme immobilization on MNPs 
Magnetite MNPs with a silica shell and amine surface functions were used to attach 
Porcine pancreas lipase (EC 3.1.1.3) through the covalent bonding, which helped to 
improve the stability and activity of the enzyme.
[35]
 Mahmood and co-workers used 
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gum Arabic as shell for magnetite MNPs and Candida rugosa lipase was immobilized 
via colvalent attachment of the enzyme to the glutaraldehyde functions and catalyzed 
ethyl isovalerate.
[93]
 Wang et al., reported MNPs with an iron oxide core and a 
poly(glycidyl methacrylate) shell. These MNPs were further functionalized using 
readily available epoxide groups to immobilize chloroperoxidase with the aid of 
covalent attachment between the enzyme and the amine groups.
[94]
 As an example for 
the encapsulation of MNPs, Ozyilmaz and co-workers coated magnetite MNPs with β-
cyclodextrin, then Candida rugosa lipase was encapsulated using aloxysilane. The 




Ngo et al., demonstrated the poly(glycidyl methacrylate) coated MNPs with aldehyde 
functions could be used for the immobilization of alcohol dehydrogenase and then 
enantioselective catalysis of 7-methoxy-2-tetralone. This nanobiocatalyst formed the 
clusters when the shaking stopped due to the zero surface charge at pH 8; thus, it could 
be quickly separated from the reaction mixture to recycle and reuse.
[96]
  
2.4.2 Reversible enzyme immobilization on MNPs 
MNPs have also been reported for the reversible enzyme immobilization.
[53]
 It is 
possible to anchor biotin molecule on the MNPs and with the aid of the streptavidin or 
avidin, immobilize the biotinylated proteins on the MNPs. However, biotinylation is 
complex and it is less common to engineer enzymes in this way. On the other hand, 
His-tagged enzymes are easy to engineer by adding polyhistidine-tag in either C or N 
terminal; hence, they are readily available in many laboratories.
[97]
 As it was elaborated 
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in section 2.2.2.3, the metal-chelates can be introduced in nanomaterials including 
MNPs to immobilize enzymes. The affinity bonding is inherently a selective 
immobilization approach
[97]
 and can provide a facile simultaneous purification and 
immobilization of His-tagged enzymes from a pool of His-tagged and untagged 
proteins. 
Xu and co-workers used cobalt MNPs with a layer of Fe2O3 and anchored dopamine on 
the particle’s surface. After attaching NTA functions and treating with nickel metal, 
these MNPs were used to immobilize His-tagged green fluorescent protein (GFP) via 
affinity bonding.
[98]
 There are some other reports, which can be classified under 




Some of the recent research works have devoted their efforts to demonstrate the 
capability of the immobilized His-tagged enzymes on the MNPs for biocatalysis. Herdt 
et al., synthesized γ-F2O3 grafted with polystyrene-b-polyacrylate, which contained 
iminodiacetic acid-Cu metal-chelate to immobilize His-tagged proteins such as T7 
RNA polymerase, GFP and T4 DNA Ligase. However, only T7 RNA polymerase could 
maintain its biological activity. The recyclability of this nanobiocatalyst was reported 
with a large decline only after three cycles.
[104]
 Abad et al., prepared gold nanoparticles 
with NTA functions and cobalt(II) ion. The immobilization of His-tagged Horseradish 
peroxidase and Ferredoxin-NADP
+
 reductase enzymes was successful and the 
immobilized enzymes almost retained their activity in the corresponding activity 
assays.
[105]
 The immobilization of an epoxide hydrolases via His-tag affinity on the iron 
oxide-silica MNPs with NiO nanoparticles on the surface was performed and used for 
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the enantioselective resolution of racemic epoxide and it was also recycled but the 
recyclability was poor.
[106]
 In another work, Wang and coworkers displayed a facile 
immobilization of an epoxide hydrolase from the CFE.
[20]
 The immobilized enzyme 
gave acceptable activity retention of 80% after immobilization and retained 80% 
productivity after eight cycles. 
These examples of reversible and irreversible enzyme immobilization on the MNPs 
give a clear image of the versatility and capability of these materials to prepare 
nanobiocatalysts with obvious advantages, which can suppress the conventional 
immobilization methods. Hence, we want to use the functionalized MNPs for affinity 
immobilization of His-tagged enzymes and study their applications as active and 
recyclable nanobiocatalysts. 
2.5 Biodiesel production with enzymes 
2.5.1 Production of biodiesel as a clean and renewable fuel 
Fossil fuels are extracted from nonrenewable resources; hence, seeking alternative fuels 
is crucial and unavoidable. Biodiesel is a diesel fuel and refers to alkyl (C1, C2 or C3) 
fatty acid esters (C14-C22).
[107]
 The‎term‎‘bio’‎implies‎its‎preparation‎from‎the‎biological‎
renewable sources such as vegetable oils and animal fats. Biodiesel stands a great 
potential as fossil fuel alternative because of its clear advantages over the fossil fuels. It 
is renewable and amongst the safest fuels with very high flash point (>130 °C).
[108]
 In 
addition, it is biodegradable and non-toxic containing no sulfur.
[109,110]
 Moreover, 





Figure ‎2.4. The worldwide annual production of biodiesel extracted from F.O. Licht’s World 
Ethanol and Biofuels Report and Renewables 2014 and 2015 Global Status Report. 
Because of the increasing production of biodiesel (see Figure ‎2.4), the governments 
paid an extra attention towards its production over the last decade, which this triggered 
research for biodiesel production. 
Fatty acid methyl esters (FAME) are a type of biodiesel that can be mainly prepared by 
reacting methanol with triglycerides of the vegetable oils and animal fats.
[113]
 Using the 
conventional base-catalysis is a common practice for this process. However, there is a 
growing concern about the utilization of edible oil feedstocks 
[114]
 because of food 
security. As a result, the increasing demand for the biodiesel and negligible growth in 
the production of vegetables oils as well as policies imposed by governments due to the 
food security concerns led to the higher price of these oils (US$/L 0.8-0.9), which is not 
favored for the biodiesel production plants and it may negatively affect the rising 




Enzymes, more specifically lipases, are significantly efficient catalysts, which provide 
cleaner reactions using low methanol to grease ratio, no corrosive reagents, easier 
separation of the glycerol and simpler downstream processing. Therefore, it is an 
environmentally friendly approach to produce biodiesel using enzymes. Several lipases 
















 were reported for the transesterification of oils from 
different resources. 
2.5.2 Biodiesel production from waste grease 
Alternative plant oils were proposed to be used as a feedstock for biodiesel production. 









 were reported for the production of biodiesel. However, these 
oils still require cultivation process, which is costly and also need vast farm lands. 
On the other hand, waste grease trap oil is nonedible and cheap (US$/L 0.2-0.3) and 
only needs a collection process from grease traps, which the infrastructures are readily 
available in many countries including Singapore. Waste grease contains triglycerides 
and about 15–40% free fatty acids (FFA).[130] This high FFA content significantly 
affects the base-catalyst performance resulting low grease to biodiesel conversion.
[131]
 
Therefore, catalysts with ability of simultaneous esterification of FFA and 
transesterification of triglycerides into the biodiesel are needed.  
Enzymes, specifically lipases, are able to catalyze simultaneous esterification and 




 is reported to be an efficient biocatalysts for this purpose even at 
high FFA content of waste grease. The overall scheme of conversion of the waste 
grease to biodiesel is displayed in Figure ‎2.5. 
 
Figure ‎2.5. Overall scheme of the biotransformation of waste grease to biodiesel. 
2.5.3 Production of biodiesel with Thermomyces lanuginosus lipase (TLL) 
Thermomyces lanuginosus lipase, also previously known as Humicola lanuginose, (EC 
3.1.1.3) is a well-known enzyme with molecular weight of 31.7 kDa and its‎ crystal‎
structure‎solved‎at‎1. ‎ .[132] It is almost spherical with characteristics of 35 Å × 45 Å × 
50 Å. It is reported to catalyze a wide range of reactions including hydrolysis of fats 
and oils, interesterification of oils, transesterification of oils, esterification of fatty acids, 
resolution of racemic mixture, enantioselective hydrolysis of prochiral esters and 
biodiesel production.
[133]
 As a result of broad uses and applications of TLL, it has been 
commercially immobilized (Lipozyme TL IM
®
) on hydrophilic silica with pore size of 
50–100 nm via adsorption of the enzyme on the carrier.[134] 
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The Lipozyme TL IM was used to carry out the transesterification of triglycerides to 
biodiesel. However, there is room to enhance the stability of this immobilized enzyme 
since it shows poor performance in the presence of methanol and reportedly inactivated 
in more than 1.5 equivalent of methanol.
[135]
  
In efforts to enhance the performance of the immobilized TLL, it was immobilized on 
different carriers and the obtained biocatalysts were used to produce biodiesel from 
different sources of oils such as soybeans and palm oil. The immobilization of TLL was 
demonstrated on hydrophilic polyurethane foams to convert canola oil to FAME with 
highest yield achieved about 90%.
[136]
 In the other work, Dizge and coworkers, used 
microporous polymeric matrix with aldehyde surface functions to achieve the covalent 
immobilization of TLL and used it for production of biodiesel from different vegetable 
oils.
[137]
 They reported a lower yield obtained for the waste cooking oil (contains higher 
FFA) compared to the vegetable oils.  
The use of MNPs for the immobilization of TLL for the biodiesel production has 
recently been reported. The MNPs with aldehyde functions were used to immobilize 
TLL through a covalent bonding, which could improve the stability of the enzyme and 
one-step addition of 4 equivalent of methanol gave 99% FAME yield.
[123]
 
2.5.4 Challenges in preparation of the immobilized enzyme for biodiesel 
production 
All aforementioned approaches for preparation of immobilized enzymes for biodiesel 
production require pure enzymes for the immobilization process. As it was described 
earlier, affinity immobilization of His-tagged enzyme on a carrier with proper functions 
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such as Ni-NTA can afford a selective immobilization of the target His-tagged enzyme 
in a pool of proteins. Therefore, it can help to avoid complicated and low-yielding 
purification steps and would decrease the cost of immobilized enzyme. 
Since the biocatalyst cost is one of the major obstacles for its uses in the large scale 
biodiesel production plants,
[107,109]
 the engineering of the recombinant microorganism 
with extracellular enzyme expression into the culture medium can save energy and 
downstream processing costs and provide a more economical and environmentally 
friendly immobilization method. It can further simplify the biocatalyst preparation 
through His-tag affinity immobilization approach since there would be no cell 
disruption step required. There are different techniques for cell disruption such as 
mechanical, physical, chemical and biological.
[138]
 Applying these processes is 
generally cost-prohibitive, especially in the large scales. For instance, a very common 
method is high pressure homogenization, which has several drawbacks such as high 
capital cost, excessive heating and possibility of protein inactivation by shear-
associated denaturation. Hence, extracellular protein expression or secretion is a useful 
alternative for intracellular expression systems. 
P. pastoris is one of the most well-known yeast hosts and can secrete protein into the 
medium efficiently by α-factor secretion signal.[139,140] It can grow to the ultra-high cell 
densities‎ (≥100‎ g‎ cdw/L) benefiting the system to produce more desired protein. 
Moreover, it produces relatively low level of native proteins
[141]
 and can be cultivated 
in a large-scale fermentation process with a simple salt medium instead of complex 
growth medium.
[142]
 Hence, P. pastoris was selected as our host system for the 
extracellular protein expression of TLL. 
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2.6 Synthesis of β-pyrazol-1-yl-alanine with O-acetylserine sulfhydrylase 
2.6.1 O-acetylserine sulfhydrylase 
O-acetylserine sulfhydrylase (EC 2.5.1.47) is a transferase, and known to involve in the 
pathway of L-cysteine biosynthesis in plants and bacteria. Two isozymes namely CysK 
and CysM exist for this enzyme, which share 43% similarity of their sequence identity. 
The crystal structure of the CysK and CysM are solved to 2.2 Å
[143]
 and 1.33 Å
[144,145]
, 
respectively. Both isozymes are pyridoxal‎ 5’-phosphate (PLP) dependent,[146] 
exhibiting different substrate specificities.
[147,148]
 Both CysK and CysM can be found in 





Figure ‎2.6. Ping-pong kinetic mechanism of the OASS CysK‎or‎CysM‎enzyme‎to‎produce‎α-
amino acids from OAS and an appropriate nucleophile. 
As it is demonstrated in Figure ‎2.6, the kinetic mechanism of OASS A/B is bi-bi ping-
pong.
[150]
 In the presence of OAS, α-aminoacrylate is formed and acetate is released 
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and then the nucleophile (bisulfide is required for cysteine biosynthesis) attacks to form 
α-amino acid. 
2.6.2 β-pyrazol-1-yl-L-alanine (PAA)  
PAA is a non-proteinogenic amino acid, which was first isolated from water melons 
(Citruilus vulgaris) and cucumbers (Cucumis sativus) and later found in several other 
species of gourds (Curcurbitaceae).
[151]
 It has been found to be vital building blocks of 
various pharmaceutical compounds and there are different ways to prepare PPA. 
2.6.3 Extraction of β-pyrazol-1-yl-alanine from gourds and chemical synthesis 
method 
The extraction of PAA from cucumber seeds was reported as only 4.24 µmol could be 
retrieved from each growing seeding after a time of 25 days. The impractical yield of 
only 0.145 mmol (about 22 mg) was also extracted from 287 g of fruit.
[151]
 
Chemical synthesis has also been attempted, employing Michael Addition and 
nucleophiles with dehydroalanine derivatives. However, the overall reaction yield was 
likewise poor with a maximum of 54%, while possessing multiple steps including resin 
loading, lengthy Michael Addition times (2 days) and the need for cleavage and 
enzymatic resolution (see Figure ‎2.7). 
 
Figure ‎2.7. Chemical synthesis route of β-pyrazol-1-yl-alanine. 
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2.6.4 Enzymatic synthesis of PAA with OASS 
As it was elaborated in the section 2.6.1, OASS can carry out the reaction of OAS with 
a‎ nucleophile‎ to‎ produce‎ α-amino acids. For the preparation of PAA through this 
method, pyrazole (PA) is required as nucleophile and both isozymes CysK and CysM 
can perform this reaction. The biotransformation route is given in the Figure ‎2.8. 
 
Figure ‎2.8. Biotransformation of the O-acetylserine and pyrazole to β-pyrazol-1-yl-alanine using 
OASS as biocatalyst. 
Whole-cell biocatalyst was applied by engineering E. coli containing CysM and use of 
growing cells to produce PAA from PA and glucose (converted to OAS).  However, 
this approach only gave 9.1 g/L (58 mM) product in 40 h reaction time.
[148]
 The 




Although the whole-cell biocatalysis was successfully attempted, the long reaction time 
due to the mass transfer limitations and lack of recyclability of biocatalyst are the main 
issues remained. 
Zhao and coworkers examined the purified CysK and were able to produce 105 mM of 
PAA in 2 h.
[153]
 This example has demonstrated the capability of the free enzyme in 
conducting faster biotransformation but the recyclability was not possible; thus, the 
biocatalyst cost remained as an important concern. 
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2.6.5 Immobilization of the OASS CysK and CysM and its challenges 
The utilization of the immobilized CysK or CysM for the synthesis of PAA can offer 
several advantages. Similar to the free enzyme, it can provide a faster reaction in 
comparison with the whole-cell system, while it can also be recycled and reused to 
enhance the productivity of this process. Therefore, it is of great interest to develop 
immobilized enzyme system for this process. 
To the best of our knowledge, the immobilized OASS CysK or CysM have not been 
reported yet. There is a challenging point in developing an active and recyclable 
enzyme system for CysK or CysM. One important phenomenon, which can interfere 
with the progress of PAA production by using OAS and PA is the isomerization of 
OAS to the N-acetylserine (NAS) at pH > 6.4,
[154]
 which is illustrated in Figure ‎2.9.  
 
Figure ‎2.9. Isomerization of OAS to NAS. 
However, both enzymes have pH preference of about 6.9–7.4.[150,155] This means for the 
batch reaction of OAS with PA, the reaction must proceed rapidly to avoid a big loss of 
limiting substrate (OAS) then it can achieve a higher product yield. 
Since the free enzyme could afford a rapid reaction to synthesize PAA using OAS, it is 
clearly important to retain the activity of the enzyme after immobilization and also to 
minimize the mass transfer issues. The mass transfer limitations of the micro- or 
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macroporous materials for the enzyme immobilization as discussed in the section 2.3.1, 
discourages from considering of these carriers for this application. 
On the other hand, the Ni-NTA-MNPs could offer low mass transfer limitations as well 
as high enzyme activity retention after immobilization, which fits into the criteria for 
the PAA production. These MNPs can be simply used for the specific His-tagged 
immobilization of the CysK and CysM from the cell free extract (CFE). 
We aimed to explore the simultaneous purification and immobilization of the His-CysK 
and CysM on the Ni-NTA-MNPs and examine the activity and recyclability of the 
obtained magnetic nanobiocatalysts for the PAA production from OAS and PA. This 
would also demonstrate that the developed Ni-NTA-MNPs are generally useful and 
applicable carriers for active and recyclable immobilized enzyme preparation.  
2.7 Synthesis of S-arylcysteines with OASS CysM 
2.7.1 Amino acids 
Amino acids are the basic organic compounds in the alphabet of life. They can be 
generally categorized into two natural (proteinogenic) or unnatural (non-proteinogenic) 
amino acids. 
Many amino acids, especially proteinogenic amino acids, have already been reported to 
be synthesized via enzymatic biocatalysis. For instance, phenylalanine, tyrosine and 
tryptophan were produced by engineered E. coli cells as biocatalyst.
[156]
 The natural and 
unnatural amino acids and their possible applications are elaborated below.  
36 
2.7.2 Natural amino acids 
The natural amino acids contain one amino group and one carboxylic group, which 
combine with a substituent (except for the glycine) to form 22 natural or proteinogenic 
amino acids in prokaryotes (21 in eukaryots) that all exist in L-stereoisomer form.  
Amino acids offer a remarkable tool to introduce the chirality in drug molecules. It is 
reported that amino acids and their derivatives contribute 18% to the synthesis of top 
500 drugs and it is growing.
[157]
 There are some amino acids that have been used the 
most for the production of the pharmaceutics including L-proline for angiotensin 
converting enzyme inhibitors, L-valine for cyclosporin,
[157]




2.7.3 Unnatural amino acids as pharmaceutical intermediates 
As a complementary to the natural amino acids, unnatural or non-proteinogenic amino 
acids do not exist in the genetic codes of any organism. They can be found in the form 
of different stereoisomer (D- instead of L-) or β and γ-amino acid, and also can be 




There are over 140 known amino acids in the nature that have been produced mostly by 
post-translational modification of proteinogenic amino acids and out of them only two 
amino acids namely selenocysteine and pyrrolysine have been identified and added to 




The unnatural amino acids can enhance the activity of the biomolecules or drug 
molecules resulting design and production of more useful drugs. Therefore, they were 
used or proposed as strong alternatives to the available drugs intermediates. For 
instance, D-p-hydroxyphenylglycine and D-phenylglycine both have application in 
antibiotic production. Another example is the Viracept as a HIV protease drug, which 
contains S-phenyl-L-cysteine and showed a high activity.
[160]
  
2.7.4 Explore the OASS CysM substrate specificity towards arylthiols for the 
synthesis of S-arylcysteines 
The importance of the amino acids in the pharmaceutical industry is a great motivation 
to conduct research for production of new unnatural amino acids. The simplicity and 
efficiency of synthesizing amino acids by OASS attracts to conduct in depth studies on 
this type of enzymes. The CysM shows higher activity towards thiols amongst two 
isozymes.
[148]
 S-phenyl-L-cysteine is an important drug intermediate that was used to 
prepare an important HIV protease inhibitor. This unnatural amino acid can be 
produced using CysM from OAS and thiophenol. However, the activity of the enzyme 
towards the different arylthiols, specially substituted thiophenols, is not known. The 
importance of the substituent on the ring can be understood when the phenylalanine and 
tyrosine (two natural amino acids) have one hydroxyl group difference on the phenyl 
ring in their chemical structure, showing distinctive functions in the nature. Therefore, 
the activity and possible selectivity of the CysM will be studied towards the substituted 
arylthiols.  
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This approach can help to understand more in depth about the substrate specificity of 
the CysM and produce new unnatural amino acids by using immobilized CysM.  
2.8 Enzymatic ring-opening polymerization catalyzed by immobilized enzymes 
The enzymatic polymerization is defined as in vitro synthesis of polymers through non-
metabolic pathways catalyzed by isolated enzymes.
[161]
 With the main focus on the 
polyesters, there are generally two approaches to synthesize polymers via enzymatic 
polymerization (with hydrolases), which are polycondensation and ring-opening 
polymerization (ROP). Also, combination of these two can be employed for the 
preparation of certain co-polymers.  
The polycondensation can be performed with either self-condensation (e.g. 
hydroxyesters) or via condensation of monomers with dicarboxylic acids (or diester) 
and diols.
[162]
 The ROP of the several cyclic monomers has also been reported for the 
enzymatic preparation of the polyesters. Several examples are illustrated in 
Figure ‎2.10.[163] Among these monomers, enzymatic ROP of some of these cyclic 
monomers became increasingly attractive due to their wide biomedical applications and 
rising concerns about the synthesized polymers by metal-based catalysts. One of the 
most famous examples is ε-caprolactone (CL), which is widely used as homo- or co-
polymer in several biomedical applications,
[164,165]
 can be synthesized via lipase 
catalyzed ROP of CL, which gives a clean polyester product with no metal remnants in 
a mild reaction conditions. 
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Generally, ROP of lactones is an important reaction to prepare polyesters from cyclic 
monomers such as CL and VL for biomedical applications.
[166-169]
 From this point of 
view, the enzymatic ROP of polyesters from cyclic monomers is of great interest to 
researchers.  
 
Figure ‎2.10. Several cyclic monomers for the enzymatic ring-opening polymerization used in 
the synthesis of polyesters. (Reprinted with permission, Copyright © 2011 John Wiley & Sons, 
Inc.)[163]  
The lipase can catalyze hydrolysis (bond-cleavage) in aqueous phase and bond-forming 
of polyesters in the organic media. Since the free enzymes are usually unstable in the 
organic media, the immobilized enzymes are mostly reported for the enzymatic 
polymerizations. The conventional immobilization of the enzyme on the macroporous 
carriers is common practice for these immobilized enzymes. However, as it was 
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elaborated in the previous sections, these immobilization supports often suffer from 
mass transfer issues affording lengthy reactions. The nanobiocatalysis on the other hand, 
can relief the mass transfer issues since the immobilized enzymes on the surface of 
nanoparticles are accessible for the large polymer molecules. Moreover, the enzyme 
loading also can be high due to the large surface area per volume of nanoparticles. The 
use of MNPs can facilitate the recovery of nanobiocatalyst, suggesting a promising 
choice to perform enzymatic polymerization. 
Therefore, the activity of the immobilized His-TLL on the MNPs that can perform 
esterification and transesterification reactions is interesting to explore for the polyester 
synthesis. The ROP of lactones as important monomers is selected for this purpose. The 
use of immobilized His-TLL on the Ni-NTA-MNPs is useful since we can study the 
activity of this lipase for ROP of lactones, evaluate the activity and stability of 
immobilized enzyme via His-tag affinity to be utilized in enzymatic polymerization, 
and explore the benefits of the using MNPs as immobilization carriers for the 
enzymatic polymerization.  
  
41 
Chapter 3 Simple and Efficient 
Immobilization of Extracellular His-Tagged 
Enzyme Directly from Cell Culture Supernatant 
as Active and Recyclable Nanobiocatalyst: High-
Performance Production of Biodiesel from Waste 
Grease 
3.1 Introduction  
Enzyme catalysis has become a useful and green tool for sustainable production of 
chemicals, fuels, and polymers.
[6-9,14,170]
 Although free enzyme often suffers from 
instability and high cost, immobilized enzymes could enhance enzyme stability and 
reduce enzyme cost via recycling. Thus, many immobilization techniques have been 
developed.
[16,18,36,41,171]
 Among them, the immobilization of enzymes on functionalized 
magnetic nanoparticles (MNPs) as nanobiocatalyst has attracted much attention due to 
the unique properties of MNPs, such as a large surface area per volume, high dispersity, 
less mass transfer limitations, and easy magnetic separation.
[21,53,56,76,172]
 Thus far, most 
enzyme immobilization methods have required prepurification of the enzyme.
[94,96,123]
 
In general, enzyme purification is costly and low-yielding.
[19,20,104]
 It is especially 
difficult to purify extracellular enzyme, which is often expressed in cell culture medium 
at low concentration. Hence, development of a simple and efficient method for direct 
immobilization of targeted extracellular enzyme from cell culture supernatant without 
prepurification is highly desirable. Here, we report such a method by the introduction of 
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His-tag into the target extracellular enzyme and the use of MNPs containing nickel-
nitrilotriacetic acid (Ni-NTA) on the surface as a carrier for highly specific attachment 
of His-tagged extracellular enzyme directly from cell culture supernatant via affinity. 
The resulted nanobiocatalyst is active and recyclable for the target biotransformation, 
and the Ni-NTA-MNPs are regenerable from the used nanobiocatalyst (see Scheme ‎3.1). 
 
Scheme ‎3.1. Immobilization of His-tagged extracellular enzyme directly from cell culture 
supernatant on magnetic nanoparticles (Ni-NTA-MNPs), biotransformation with and recycling 
of the nanobiocatalyst, and regeneration of Ni-NTA-MNPs from the used catalyst. 
TLL
[133,173,174]
 is chosen as target extracellular enzyme to demonstrate the simple 
immobilization method and the practical application of the immobilized enzyme. TLL 
is known to catalyze the transesterification reaction for the production of biodiesel 
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(fatty acid methyl esters, FAMEs),
[120,133,135]
 a clean and renewable alternative to 
petroleum diesel,
[112,114]
 from vegetable oils via methanolysis. However, vegetable oils 
are edible and costly.
[175]
 Recently, waste grease has become an attractive feedstock for 
biodiesel production since it is nonedible and cheap (0.3 USD/kg). Due to the high free 
fatty acid (FFA) content (15−40 wt%) of waste grease,[176-178] the conventional base 
catalysis process is not applicable. Also, two-step process involving acid-catalyzed 
esterification of FFA and subsequent base-catalyzed transesterification of triglycerides 
is not efficient.
[179]
 In our continuous effort to develop one-pot esterification and 
transesterification process for efficient transformation of waste grease to 
biodiesel,
[121,122,180,181]
 immobilized TLL was shown as suitable biocatalyst for this 
transformation.
[123]
 Nevertheless, the requirement of the enzyme purification has been a 
bottleneck in developing cost-effective processes to produce the immobilized enzyme 
as well as the biodiesel from waste grease.  
3.2 Experimental section 
3.2.1 Chemicals and Strains  
Waste‎grease‎(containing‎24%‎FFA)‎collected‎from‎grease‎traps‎in‎Singapore’s‎sewage‎
system was donated by Alpha Synovate Pte Ltd, Singapore. Analytical standard of 
FAME (GLC-10) mixture was obtained from Sigma–Aldrich. Methanol (99%) and n-
hexane (>99%) were obtained from Tedia (US). Potassium oleate (40 wt% in H2O), 
ferric chloride hexahydrate (97%), ferrous chloride tetrahydrate (99%), ammonium 
hydroxide (28% NH3 in H2O), ammonium persulfate (≥9 %), glycidyl methacrylate 
(97%), 4,7,10-trioxa-1,13-tridecanediamine (97%), glutaraldehyde solution (25% in 
44 
H2O), Nα,Nα-bis(carboxymethyl)-L-lysine hydrate (≥97%), t-butanol (>99%), 
ethylenediaminetetraacetic acid (EDTA)‎(≥99%), and p-nitrophenyl butyrate (>98%, p-
NPB) were purchased from Sigma–Aldrich. All salts and chemicals for Basel Salts 
Medium (BSM) and PTM1 (trace salts) were purchased from Sigma–Aldrich with 
purity of‎≥95%.  
Pichia pastoris X-33,‎ expression‎ vector‎ pPICZαA, and zeocin were obtained from 
Invitrogen. Restriction enzymes EcoRI and NotI, T4-DNA ligase, and Taq DNA 
polymerase were purchased from New England Biolabs (Beverly, MA). QIAprep spin 
plasmid mini-prep kit and QIAquick PCR purification kit were purchased from Qiagen 
(Hilden, Germany). Oligonucleotide primers were obtained from 1st BASE. Optimized 
gene of Thermomyces lanuginosus lipase (TLL) (accession number AF054513.1) and 
Candida antarctica lipase B (CALB) (accession number Z30645.1) were obtained from 
Genscript Singapore. 
3.2.2 Analytical methods 
The size and morphology of magnetic nanoparticles (MNPs) were analyzed using a 
JEOL:JEM-2010 transmission electron microscope (TEM) and a JEOL:JSM-6700F 
field emission scanning electron microscope (FESEM), respectively. The size 
distribution and hydrodynamic diameter of MNPs were characterized by using zetasizer 
(Molvern). FTIR was acquired on a Bio-Rad Spectrometer of FTS 135 by averaging 16 
scans in frequency range of 4000-400 cm
-1
 with 4 cm
-1
 resolution and KBr technique. 
FAME yield was determined by GC analysis using Agilent 7890A GC system equipped 
with a capillary column (INNOWAX, Agilent, 30 m × 0.25 mm × 0.25 µm) and flame-
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ionization‎detector.‎The‎column‎ temperature‎was‎ increased‎ from‎150‎ to‎225‎ ˚C‎at 15 
˚C/min,‎ increased from‎225‎to‎260‎˚C‎at 5‎˚C/min, and‎kept‎at‎260‎˚C‎for‎3‎min.‎The‎
temperatures of injector and detector were 240‎ and‎ 2 0‎ ˚C,‎ respectively. Retention 
times of methyl esters of palmitic, linolenic, oleic, stearic, and nonadecanoic acids 
(internal standard) are 7.24, 8.85, 9.09, 9.52, and 9.83 min, respectively. 
The FFA content was determined by titration using 20 mM KOH with an 877 Titrino 
plus volumetric titrator (Metrohm) to reach pH = 8.2. 
3.2.3 Engineering of P. pastoris (h-TLL) expressing extracellular His-tagged TLL 
The synthesized tll and calb gene (without the 51 bp signal peptide sequence) were 
amplified‎ by‎ polymerase‎ chain‎ reaction‎ (PCR)‎ with‎ the‎ forward‎ primer‎ of‎ (5’-
GCTGAATTCAGTCCTATTCGTCGAGAGG-3’,‎ the‎ EcoRI‎ restriction‎ site‎ is‎
underlined) and the reverse primer‎ of‎ (5’-
GCTGGCGGCCGCAAGACATGTCCCAATTAACC-3’,‎ the‎ NotI‎ restriction‎ site‎ is‎
underlined). After purification with QIAquick PCR purification kit, the PCR product 
and‎plasmid‎pPICZαA,‎which‎contained‎His-tag at its C-terminal, were digested with 
restriction enzymes EcoRI and NotI, and then ligated with T4 ligase at room 
temperature‎for‎1‎h.‎The‎resulting‎plasmid‎(pPICZαA-h-TLL/CALB) (Scheme ‎3.2) was 
transformed into chemical competent E. coli DH5α‎cells, which were then grown on 
LB agar plates containing 25 µg/mL zeocin. The colonies were screened and the 
positive ones were‎ confirmed‎ by‎ PCR‎ and‎ sequencing.‎ The‎ pPICZαA-h-TLL/CALB 
plasmid was isolated from the E. coli strain and then linearized by PmeI. 3 μg linearized 
pPICZαA-h-TLL plasmid was transformed into 50 μL competent P. pastoris X-33 cells 
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according‎to‎the‎protocol‎of‎EasyComp™‎Transformation.‎The‎entire‎transformed‎cell‎
culture was spread for growth and selection on YPD plates containing 100 μg/mL 
zeocin. The plates were incubated at 30 °C for 5 days, and finally 6 colonies for each P. 
pastoris (h-TLL) and P. pastoris (h-CALB) were picked for the cell growth and protein 
expression. 
 
Scheme ‎3.2. The engineered plasmid pPICZαA-h-TLL. 
47 
3.2.4 Medium preparation and cell growth 
Buffered glycerol-complex medium (BMGY) containing 1% (w/v) yeast extract, 2% 
(w/v) peptone, 1% (w/v) glycerol, 1.34% (w/v) yeast nitrogen base, and 4 × 10
−5
% (w/v) 
biotin (sterilized by passing through 0.2 µm filter) in 100 mM potassium phosphate 
buffer (pH 6).  
Buffered methanol-complex medium (BMMY) was prepared with same components of 
BMGY but without glycerol. 
1 L Basal Salts Medium (BSM) was prepared with following components’‎
concentrations: 0.47 g CaSO4·2H2O, 9.1 g K2SO4, 7.5 g MgSO4·7H2O, 4.13 g KOH, 
13.35 mL H3PO4 (85%), 40.0 g glycerol, and 4.35 mL PTM1 (trace salts). PTM1 
contains 6 g/L CuSO4·5H2O, 0.08 g/L NaI, 3 g/L MnSO4·H2O, 0.5 g/L CoCl2, 20 g/L 
ZnCl2, 0.02 g/L H3BO3, 0.2 g/L Na2MoO4·2H2O, 65 g/L FeSO4·7H2O, 0.2 g/L biotin, 
and 0.5 mL 9 N H2SO4. This medium was sterilized by filtration and stored at room 
temperature. The methanol feed was prepared by the addition of 12 mL PTM1 into 988 
mL methanol. 
Cells were inoculated into 25 mL BMGY. Cultivation was conducted at 250 rpm and 
30 ºC to reach OD600 = 4-6 within 18 h. Cells were harvested by centrifugation and the 
supernatant was decanted. The cells were inoculated into 100 mL BMMY without 
glycerol for protein induction. 0.5 mL methanol was added in the beginning and every 
24 h. The OD600 of the culture reached to 50 in 2 days. 
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3.2.5 High cell-density fed-batch cultivation of P. pastoris (h-TLL) in bioreactor 
Seed culture of P. pastoris (h-TLL) was grown in 50 mL BMGY at 250 rpm and 30‎˚C‎
overnight to reach OD600 of 8. Cells were harvested at 3000 g for 5 min under sterilized 
condition and inoculated in 1 L BSM at pH 5.5 and 30 ˚C in Biostat® B plus (2 L) 
bioreactor. The pH was maintained at 5.5±0.1 using 25% NH4(OH) and 25% 
phosphoric acid. The aeration was at 1 L/min and the stirring at 500 rpm. The methanol 
fed-batch started at 23 h with a rate of 3.5 mL/h, after great increase in the dissolved 
oxygen (DO) value due to the consumption of all glycerol. The aeration and stirring 
were then increased to 2.2 L/min and 1100 rpm, respectively. The flow-rate was 
gradually increased by checking DO spikes to 8.5 mL/h at 28 h and then kept constant. 
Samples (10 mL) were taken at different time intervals to monitor the cell growth, 
secreted protein concentration, and specific activity. The cultivation was stopped at 67 
h to reach 73 g cdw/L (OD600=330). Cells were harvested by centrifugation, and the 
supernatant was stored at -80 ˚C for future utilization.  
3.2.5.1 Measurement of cell dry weight, protein concentration, and activity 
To measure cell dry weight (cdw), 2 mL culture medium taken from bioreactor were 
centrifuged‎at‎21500‎g‎and‎10‎˚C‎for‎5‎min.‎The‎cell‎pellets‎were‎separated‎and‎then‎
washed with 1% NaCl (w/v) in de-ionized (DI) water. The cells were dried by heating 
for 21 h and weighed to determine cdw. 
The protein concentration of culture supernatant of the samples taken from bioreactor 
was measured by using Bradford reagent. The specific activity was determined by 
adding 10 µL p-nitrophenyl butyrate (p-NPB, 50 mM in acetonitrile) into the mixture of 
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10 µL culture supernatant and 980 µL KP buffer (100 mM, pH 8) and following UV 
absorption at 400 nm for 5 min. 1 unit (U) is defined as 1 µmol p-nitrophenol produced 
in 1 min. 
3.2.6 Preparation of Ni-NTA-magnetic nanoparticles (MNPs)  
The PGMA-MNPs with iron oxide core and poly(glycidyl methacrylate) shell were first 
synthesized according to a published procedure 
[94]
. 30 mL PGMA-MNPs in DI water 
(10 mg/mL, 63 nm) were then treated with 3.0 mL (13 mmol) 4,7,10-trioxa-1,13-
tridecanediamine at 80 ºC for 18 h to give TDA-MNPs, which were separated by 
centrifugation at 21000 g for 15 min or by magnet. The obtained MNPs were 
resuspended in 30 mL DI water, and the mixture was slowly added to 30 mL 
glutaraldehyde (GA) at 700 rpm and 80 ºC. The reaction was stopped after 3 h to give 
GA-MNPs, followed by centrifugation at 21000 g for 15 min or magnetic separation. 
The separated GA-MNPs were redispersed in 20 mL DI water, and 3 mL Nα,Nα-
bis(carboxymethyl)-L-lysine hydrate solution (0.05 M in 100 mM KP buffer pH 8) were 
added dropwise at r.t. under stirring. After 24 h reaction, the mixture was centrifuged at 
12000 g for 10 min or separated magnetically. The obtained MNPs were resuspended in 
15 mL DI water, 0.5 mL NiCl2 (1 M) was added dropwise at r.t., and the mixture was 
stirred for 2 h to give Ni-NTA-MNPs. The particles were separated by centrifugation at 
12000 g for 10 min or under magnetic field, washed with 10 mL DI water, and 
resuspended in 10 ml DI water to give a concentration of 25 mg/mL. The overall yield 
is 83% from PGMA-MNPs. 
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3.2.6.1 Scale-up of the preparation of Ni-NTA-MNPs from PGMA-MNPs 
 The same procedure was used for scaling up by 10 times. Starting from 3.00 g PGMA-
MNPs, 2.0 g Ni-NTA-MNPs was obtained in 67% overall yield. 
3.2.7 General procedure for simultaneous purification and immobilization of 
extracellular His-TLL from cell culture supernatant using Ni-NTA-MNPs 
1 mL cell culture supernatant of P. pastoris (h-TLL) with protein concentration of 0.6 
was incubated with Ni-NTA-MNPs (4.8-8.4 mg/mL) in a tube tumbler at 30 rpm, given 
temperature (4, 25, or 35 ˚C), and given pH (5.5 or 8) for 2 h. After incubation, the 
MNPs containing His-TLL (His-TLL-MNPs) were separated using a magnet and 
washed several times with DI water. The amount of immobilized His-TLL was 
determined by measuring protein concentration in the supernatant before and after the 
immobilization as well as in the DI water. The total activities of 1 mL cell culture 
supernatant before the immobilization and the obtained His-TLL-MNPs re-suspended 
in 1 mL KP buffer were determined by using p-NPB assay. Enzyme loading efficiency 
(%) =  
immobilized‎His-enz.‎(mg)
total‎His-enz.     ‎in‎cell‎culture‎supernatant








3.2.8 General procedure for biotransformation of grease with methanol to 
biodiesel by using His-TLL-MNPs as catalyst 
To a mixture of 1 g grease (24 wt% FFA), 0.2 g silica gel micro-beads, and 50 mg 
lyophilized His-TLL-MNP in a round bottom flask was added methanol stepwise in 
three portions (63 µL for each portion at 0, 2, and 6 h; total molar ratio of methanol to 
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FFA of 5.5:1) or one-shot (189 µL in the beginning). The reaction mixture was stirred at 
500‎ rpm‎and‎ a‎ given‎ temperature‎ (30,‎ 40‎ or‎ 50‎ ˚C).‎To‎ analyze‎FAME‎yield,‎ 60‎µL 
reaction mixtures were taken out at desired time points. The biotransformation was 
stopped after 24 h, followed by centrifugation to separate FAME. The catalyst was then 
separated from Silica by using magnet. The FAME product was collected and then 
washed with DI water at 1:1 (v/v) ratio. The upper layer was separated, dried over 
sodium sulfate, and centrifuged to give FAME.  
3.2.9 Preparation of His-CALB-MNPs, esterification of FFA content of waste 
grease by using His-CALB-MNPs and its recycling 
3.2.9.1 His-CALB-MNPs preparation 
1 mL cell culture supernatant of P. pastoris (h-CALB), containing total protein 0.3 
mg/mL was incubated with 2.4 mg Ni-NTA-MNPs in a tube tumbler at 30 rpm, pH 8 
and room temperature for 2 h. After incubation, the obtained His-CALB-MNPs were 
separated by a magnet and washed with DI water. The amount of immobilized His-
CALB was determined by measuring protein concentration in the supernatant before 
and after the immobilization as well as in the DI water. The activities of obtained His-
CALB-MNPs, which resuspended in 1 mL KP buffer and also 1 mL cell culture 
supernatant before the immobilization, were determined by using p-NPB assay. 
3.2.9.2 Esterification of FFA content of waste grease  
18 mg (4.5 wt% grease) His-CALB-MNPs were added into 0.4 g grease. Three portions 
of methanol (18.3 µl) were added stepwise in the beginning, after 3 and 6 h in total 
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amount of 1:1 molar ratio of methanol to grease. The biotransformation was carried out 
using‎tube‎tumbler‎at‎30‎rpm‎and‎30‎˚C‎for‎12h.‎Afterwards,‎ the‎nanobiocatalyst‎was‎
separated using magnet and supernatant was washed with 1:1 v/v of DI water. The 
remaining FFA content and FAME yield were analyzed by titrator method and GC, 
respectively. 
3.2.9.3 Recycling His-CLAB-MNPs 
The nanobiocatalyst was separated from the esterification product and washed with n-
hexane (1 × 1 mL) then air-dried to utilized for the next cycle following the 
aforementioned esterification procedure.   
3.2.10 Recycling and reuse of His-TLL-MNPs for biotransformation of grease to 
biodiesel 
A mixture of 1 g waste grease (24 wt% FFA), 50 mg His-TLL-MNPs, and 0.2 g silica 
gel micro-beads was stirred at 500 rpm and 50 ˚C for 24 h, with the stepwise addition 
of methanol (63 µL for each portion at 0, 2, and 6 h). The reaction mixture was 
centrifuged at 8000 g for 3 min, and the supernatant was taken for FAME analysis. The 
nanobiocatalyst and silica beads were washed with t-butanol (1 mL), and the 
nanobiocatalyst was separated by using magnet. After air-dry overnight, the recovered 
nanobiocatalyst was used for new batch of biotransformation of grease with methanol 
under the same conditions as described for the previous batch. 
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3.2.11  Regeneration of Ni-NTA-MNPs from His-TLL-MNPs and re-
immobilization of His-TLL on the regenerated particles for biotransformation of 
grease to biodiesel 
After 7 times’ reusing of His-TLL-MNPs from the recycling experiments described 
above, His-TLL-MNPs (50 mg) were separated under magnet and washed with 500 
mM imidazole to remove His-TLL. The obtained particles were washed with EDTA 
(0.1 M, pH 8) to remove imidazole and then washed with DI water. The particles were 
resuspended in 2 mL DI water and reacted with NiCl2 (100 mM) at r.t. for 2 h to give 
the regenerated Ni-NTA-MNPs in 100% yield (50 mg). The MNPs (4.8 mg) were 
utilized again for simultaneous purification and immobilization of extracellular His-
TLL from 1 mL cell culture supernatant of P. pastoris (h-TLL) at 8:1 ratio of MNPs to 
protein (w/w), r.t., and pH 8 for 2 h. After separation, the His-TLL-MNPs were used for 
activity test by using p-NPB assay. 
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3.3 Results and discussion  
3.3.1 Synthesis and characterization of the Ni-NTA-MNPs 
To demonstrate the immobilization method, Ni-NTA-MNPs were synthesized by the 
route shown in Scheme ‎3.3. PGMA-MNPs (60 nm by TEM) containing an iron oxide 
core (15 nm by TEM) and poly (glycidyl methacrylate) shell were synthesized 
according to the published method
[94]
 and then functionalized with a long-chain 
diamine to give TDA-MNPs (63 nm by TEM). The introduction of the long arm on the 
surface of the MNPs was to provide more space and flexibility for the enzyme to be 
attached to retain its enzymatic activity. The aldehyde group was then introduced to 
form GA-MNPs (63 nm by TEM). Further reaction with Nα,Nα-bis(carboxymethyl)-L-
lysine hydrate and subsequently nickel(II) chloride gave Ni-NTA-MNPs (63 nm by 
TEM) in 83% overall yield from PGMA-MNPs.  
 
Scheme ‎3.3. Route for synthesizing Ni-NTA-MNPs and preparing nanobiocatalyst His-TLL-
MNPs. 
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The size and morphology of the MNPs synthesized in each step were characterized by 
TEM, FESEM, and DLS. The core-shell structure MNPs in all steps was confirmed by 
TEM images and it showed a spherical shape of particles with average size of 60–63 
nm. Also, the spherical shape as well as the narrow dispersity of the synthesized MNPs 
observed by FESEM image of Ni-NTA-MNPs. These TEM and FESEM images are 
given in Figure ‎3.1. 
 
Figure ‎3.1. TEM images of a) TDA-MNPs, b) GA-MNPs, and c) Ni-NTA-MNPs. FESEM 
image of Ni-NTA-MNPs. 
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Figure ‎3.2. Size distribution measured by dynamic light scattering (DLS). a) OA-MNPs, b) 
PGMA-MNPs, c) TDA-MNPs, d) GA-MNPs, and e) Ni-NTA-MNPs. 
DLS measurement of the Ni-NTA-MNPs (Figure ‎3.2) revealed that the hydrodynamic 
size of the MNPs gradually increased after each functionalization step. The formation 
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of aggregates of the functionalized MNPs can be a possible reason which in fact the 
new hydrophilic functions such as glutaraldehyde or NTA cause the stronger 
interactions between particles and some particles aggregate in absence of mixing. The 
hydrodynamic size of the Ni-NTA-MNPs was reached to 440 nm. 
3.3.2 Engineering of P. pastoris (h-TLL) and cultivation of P. pastoris (h-TLL) in 
bioreactor 
Extracellular His-tagged TLL (His-TLL) was produced by the engineering of P. 
pastoris (h-TLL) containing‎ pPICZαA-his-TLL plasmid[139] and the high cell-density 
cultivation in a bioreactor.
[182]
 As shown in Figure ‎3.3, the cells were in lag-phase in 
first 13.5 h and reached log-phase afterward to give 25 g cdw/L at 23 h. At that time, an 
abrupt rise in the dissolved oxygen value was observed, which implies that glycerol as 
the carbon source was limited. The protein induction was started by feeding methanol 
at 23 h, leading to a gradually increased protein concentration and culture supernatant 
activity. After 13 h of induction, the volumetric activity started to increase with a big 
and almost constant slop. At the end of the fermentation (67 h), volumetric activity of 




Figure ‎3.3. Cell growth, protein secretion, and enzyme activity during the fed-batch cultivation 
of P. pastoris (h-TLL) in bioreactor: cell density (), volumetric activity (), and protein 
concentration (). The arrow indicates the starting time point of continuous feeding of methanol 
for protein induction. 
 
Figure ‎3.4. SDS–PAGE. Lane M: protein marker; lanes 1, 2, 3, 4 and 5: cell culture 
supernatant obtained from the fermentation of P. pastoris (h-TLL) in the bioreactor at 23 h, 36 
h, 45 h, 60 h, and 67 h, respectively; lane 6: supernatant (67 h) after simultaneous purification 
and immobilization with Ni-NTA-MNPs; lane 8: elute of washing His-TLL-MNPs with 10 mM 
imidazole; and lane 7: elute of subsequent washing of His-TLL-MNPs with 250 mM imidazole. 
SDS-PAGE of the cell culture supernatant taken at different time points (Figure ‎3.4) 
showed a clear rising of expression level of His-TLL (at 35 kDa) after induction, and 
gave a very significant band of His-TLL for the culture supernatant produced at 67 h. 
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The expression level of His-TLL was deduced as 60% of the total extracellular protein, 
on the basis of the purification of His-TLL from a small portion of the 67 h-cell culture 
supernatant. 
3.3.3 Simultaneous purification and immobilization of extracellular His-TLL 
using Ni-NTA-MNPs 
Ni-NTA-MNPs were added to the 67h culture supernatant after removing the cells to 
selectively immobilize His-TLL via affinity bonding between the His-tag and the Ni-
NTA function. The immobilization was performed under different conditions, and the 
enzyme loading efficiency was calculated on the basis of the His-TLL content in the 
supernatant before and after immobilization. Treatment of the culture supernatant with 
MNPs at 12:1 mass ratio of MNPs to total protein was examined for 2−8 h, and no 
significant effect on the immobilization was observed. Evidently, 2 h of incubation time 
was enough for completing the immobilization due to the high affinity. The temperature 
effect was also investigated. The specific enzyme loading and enzyme loading 
efficiency increased from 27.9 to 43.5 mg/g MNPs and from 53% to 89%, respectively, 
when the temperature increased from 4 to 25 °C (Figure ‎3.5). A further increase in the 
temperature from 25 to 35 °C gave a much lower increase in the both performance 




Figure ‎3.5. Temperature effect on specific enzyme loading () and enzyme loading efficiency 
() at 12:1 ratio of MNPs to protein (w/w) and pH=5.5. 
The impact of different mass ratios of the MNPs to total protein on the immobilization 
was investigated at r.t. for 2 h. 
 
Figure ‎3.6. The key performance parameters of simultaneous purification and immobilization 
of His-TLL from the culture supernatant  at room temperature and pH 5.5 with Ni-NTA-MNPs  
at different ratio (w/w) of MNPs to total protein (His-TLL: 60%): a) Specific enzyme loading 
(Δ)‎and‎enzyme‎loading‎efficiency‎(). b) Specific activity () and total activity recovery (□). 
The data are the mean values with standard deviation from experiments run in triplicate. 
As shown in Figure ‎3.6, an increase in the ratio from 8:1 to 14:1 decreased nearly 
linearly the specific enzyme loading from 54 to 38 mg/g MNPs and increased linearly 
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the enzyme loading efficiency from 75% to 95%, since more particles were used. An 
increase in the ratio from 8:1 to 12:1 improved nearly linearly the specific activity of 
the immobilized enzyme from 6.8 to 8.3 U/mg enzyme determined by using the p-NPB 
assay for 5 min. An increase in the ratio from 8:1 to 12:1 also enhanced the recovery of 
total enzyme activity from 71% to 106%. The slightly higher than 100% activity 
recovery is possibly due to the slight increase in the enzyme activity after 
immobilization. A further increase in the ratio from 12:1 to 14:1 did not significantly 
further increase the activity recovery and specific activity. The MNPs-to-protein mass 
ratio of 12:1 seems to be appropriate, in the view of the two key performance 
parameters. 
The aforementioned immobilization experiments were performed at pH 5.5, at which 
the cells were cultivated. The immobilization method was then examined at other pH 
values. The cell culture supernatant was adjusted to pH 8.0, followed by immobilization 
at an 8:1 (w/w) ratio of MNPs to protein and r.t. for 2 h. This gave a specific enzyme 
loading of 61 mg/g MNPs, enzyme loading efficiency of 84%, specific enzyme activity 
of 8.3 U/mg His-TLL, and full enzyme activity recovery. In comparison with pH 5.5, 
these key performance parameters are remarkable. Considering the advantages of using 
less MNPs and neutral pH, an 8:1 (w/w) ratio of MNPs to protein and a pH of 8.0 were 
chosen as the optimal conditions for the enzyme immobilization. 
The immobilization procedure was scaled up from 1 to 10 mL of the culture 
supernatant. As listed in Table ‎3.1, the specific enzyme loading of 62 mg/g MNPs, 85% 
enzyme loading efficiency, specific activity of 8.2 U/mg His-TLL, and 100% total 
activity recovery were obtained. These key performance indicators are nearly the same 
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as those obtained in 1 mL scale, which indicated the potential of using this method for 
larger scale enzyme immobilization. 
Table ‎3.1. Key parameters of simultaneous purification and immobilization of extracellular 























His-TLL-MNPs 1.0  61 ± 2 84 8.33 ± 0.30 105 ± 4 
His-TLL-MNPs 10.0  62 ± 3 85 8.20 ± 0.80 100 ± 6 
His-CALB-MNPs 1.0 70 ± 5 94 1.08 ± 0.15 93 ± 4 
a) The immobilization was performed with cell culture supernatant of P. pastoris (h-TLL) (total 
protein concentrations of 0.6 mg TLL/mL containing 60% His-TLL) or P. pasoris (h-CALB) 
(total protein concentrations of 0.3 mg CALB/mL with 60% His-CALB) at 8:1 (w/w) ratio of 
Ni-NTA-MNPs to total protein and room temperature. All the experiments were carried out in 
triplicate and the data are the mean values with standard deviation. b) Enzyme loading 
efficiency refers to [immobilized His-enzyme (mg)/ total His-enzyme (mg) in cell culture 
supernatant] × 100. c) Specific activity was determined by using p-NPB assay for 5 min. d) 
Activity recovery was based on the total activity of the cell culture supernatant. Slightly higher 
than 100% activity recovery was obtained for His-TLL-MNPs, possibly due to the slightly 
increased enzyme activity after immobilization.
[35,36]
 
3.3.4 Characterization of the nanobiocatalyst (His-TLL-MNPs) 
The nanobiocatalyst His-TLL-MNPs were analyzed by FESEM. As shown in 
Figure ‎3.7, His-TLL-MNPs are uniformed spherical particles with a diameter of about 
80 nm, which is slightly bigger than Ni-NTA-MNPs (63 nm by TEM).  
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Figure ‎3.7. FESEM image of His-TLL-MNPs. 
In the FTIR spectra of His-TLL-MNPs and Ni-NTA-MNPs, which are represented in 
Figure ‎3.8, the NTA groups on the surface gave characteristic broad absorption at 3400 
cm
-1




Figure ‎3.8. FTIR spectra. i) Ni-NTA-MNPs and ii) His-TLL-MNPs. 
The SDS-PAGE (Figure ‎3.4) was used to confirm the selective immobilization of His-
TLL with Ni-NTA-MNPs. The protein band at 35 kDa of the supernatant was 
significantly reduced after immobilization. The nanobiocatalyst His-TLL-MNPs were 
washed with 10 mM imidazole, and no protein was washed off. Further washing the 
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nanobiocatalyst with 250 mM imidazole gave a single protein band at 35 kDa for his-
TLL in the SDS-PAGE of the elute. This indicates that only His-TLL was attached on 
Ni-NTA-MNPs.  
3.3.5 Biotransformation of grease to biodiesel using nanobiocatalyst His-TLL-
MNPs 
The His-TLL-MNPs were used for the production of biodiesel (FAME) from waste 
grease containing 24 wt% FFA via simultaneous esterification of FFA and 
transesterification of triglyceride (TG) with methanol. The general biotransformation 
scheme of biodiesel preparation from waste grease is presented in Figure ‎3.9.  
 
Figure ‎3.9. Biotransformation of waste grease (24% FFA) to biodiesel (FAME) by using 
nanobiocatalyst His-TLL-MNPs via simultaneous esterification of FFA and transesterification 
of TG with methanol. 
The temperature and methanol addition were studied for efficient biotransformation. 
The reaction was performed by using 1 g waste grease and 50 mg His-TLL-MNPs with 
stepwise (63 µL × 3) or one-shot (189 µL) addition of methanol at 30-50 °C for 24 h. 
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Silica gel micro-beads (20 wt%) were added in the reaction system to improve the 
FAME yield via the absorption of water. 
The FAME yield was obtained based on GC analysis. A representative GC 
chromatogram is given in Figure ‎3.10.  
 
Figure ‎3.10. GC chromatogram of FAME produced from the biotransformation of grease (1 g) 
with His-TLL-MNPs (5 wt% loading) and stepwise addition of methanol (63 µL each portion at 
0, 2, and 6 h, respectively) at 50 ºC for 24 h. Methyl esters of palmitic, linolenic, oleic, and 
stearic acids showed retention times of 7.24, 8.85, 9.09, and 9.52 min, respectively. 
Nonadecanoic acid methyl ester was used as internal standard with a retention time of 9.83 min. 
One-shot addition of methanol (entry 3, 40 °C) gave 74% FAME yield while stepwise 
addition of methanol (entry 2, 40 °C) gave 81% FAME yield. The increased yield was 
due to the reduced toxicity of methanol to the enzyme through stepwise addition. Under 
stepwise addition of methanol, the FAME yield was increased from 81% at 40 °C 
(entry 2) to 94% at 50 °C (entry 4).Consequently, 50 °C is better for this reaction. 
These results are tabulated in Table ‎3.2. 
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The activity of free TLL for the conversion of waste grease to FAME was also 
investigated under reaction conditions of entry 4 in Table ‎3.2, exhibiting 92% FAME 
yield with stepwise methanol addition, which is slightly lower than yield obtained from 
His-TLL-MNPs. 
Table ‎3.2. One-pot biotransformation of waste grease to FAME via simultaneous esterification 














yield (%)   
1 1.00 5.0 stepwise b 24 30 62 
2 1.00 5.0 stepwise b 24 40 81 
3 1.00 5.0 one-shot c 24 40 74 
4 1.00 5.0 stepwise b 24 50 94 
a) Catalyst loading refers to grease. b) Three equal portions of methanol (63 µL in each portion) 
were added at 0, 2, and 6 h, respectively. c) Methanol (189 µL) was added in the beginning. 
Different catalyst loadings were examined at 50 °C and the time courses for these 
biotransformations are given in Figure ‎3.11. The highest FAME yield (94%) was 
achieved with 5 wt% catalyst loading. Nevertheless, at 3 wt% and 4 wt% catalyst 
loading, FAME was also obtained in 87% and 89% yield, respectively. The average 
specific activity within the first 20 min for the conversion of grease to FAME at 3 wt% 
catalyst loading was determined as 10.5 U/mg His-TLL or 0.6 U/mg His-TLL-MNPs. 
In these biotransformations, no FFA remained in the final reaction mixture, determined 
by titration.  
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Figure ‎3.11. Time courses of the biotransformations of waste grease (1 g) to FAME by using 
nanobiocatalyst His-TLL-MNPs at 3 wt% (), 4 wt% (), and 5 wt% () loading, 
respectively, with stepwise addition of methanol (at 0, 2, and 6 h with 63 µL in each portion) at 
50 °C. All experiments were carried out in triplicate and presented data are the mean values 
with standard deviation. 
3.3.6 Recycling and reuse of His-TLL-MNPs for biotransformation of grease to 
biodiesel 
The recyclability of the nanobiocatalyst His-TLL-MNPs was examined by the reaction 
of 1 g waste grease and methanol (63 µL × 3) with 50 mg His-TLL-MNPs and 0.2 g 
silica gel micro-beads at 50 °C for 24 h. After each batch, the nanobiocatalyst His-TLL-
MNPs were separated from the reaction mixture and silica gel by using a magnet. The 
catalyst was washed and reused for the next batch of biotransformation of grease to 
FAME under the same conditions. As shown in Figure ‎3.12.a, the recyclability of the 
nanobiocatalyst was excellent, retaining 97% productivity in the 7
th
 cycle.  
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Figure ‎3.12. a) Recycling and reuse of His-TLL-MNPs in the biotransformation of waste 
grease (1 g) to FAME at 5 wt% catalyst loading and 50 °C with stepwise addition of methanol. 
b) Magnetic separation of His-TLL-MNPs from FAME for catalyst recycling. 
The observed high recyclability of the nanobiocatalyst is partially due to the easy and 
almost full recovery of the MNPs (Figure ‎3.12.b). Other reason is the strong affinity 
attachment of enzyme on the MNPs, giving no detectable enzyme leakage during 
bioconversion and recycling experiments. Moreover, the immobilized enzyme is highly 
stable,‎ as‎ demonstrated‎ in‎ the‎ 7‎ days’‎ reactions‎ during‎ recycling‎ experiment‎with‎ no‎
significant loss of the enzyme productivity. The recycling and reusing of the 
nanobiocatalyst can significantly reduce the cost of catalyst, and thus reduce the 
biodiesel production cost. 
3.3.7 Regeneration of Ni-NTA-MNPs from His-TLL-MNPs after 7 cycles of 
biotransformation 
The possibility of regenerating Ni-NTA-MNPs from His-TLL-MNPs was also 
examined. The nanobiocatalyst recovered after 7 cycles of biotransformation with a 
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total reaction time of 7 days was first washed with 500 mM imidazole to remove His-
TLL. After further treatment with EDTA to remove imidazole, the MNPs were washed 
with water and treated with nickel (II) chloride to give Ni-NTA-MNPs in 100% yield. 
These steps are illustrated in Figure ‎3.13. 
 
Figure ‎3.13. Regeneration of the recycled and reused His-TLL-MNPs. 
The regenerated MNPs were used again for one-pot immobilization of His-TLL from 
the cell culture supernatant of P. pastoris (h-TLL) under previously established optimal 
conditions, giving the enzyme loading efficiency, activity recovery, and specific 
enzyme loading of 65%, 80%, and 49 mg/g MNPS, respectively. Thus, the regenerated 
Ni-NTA-MNPs reached 80% of these key enzyme immobilization performance 
parameters of the freshly synthesized Ni-NTA-MNPs. The specific activity of the 
nanobiocatalyst prepared from the regenerated particles reached 8.4 U/mg His-TLL for 
the hydrolysis of p-NPB, was the same as those of the nanobiocatalyst prepared from 
the freshly synthesized particles. The efficient regeneration of Ni-NTA-MNPs from the 
used catalysts and reuse of the particles for enzymatic immobilization reduce the cost of 
the nanocarrier. 
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3.3.8 Preparation of His-CALB-MNPs to convert FFA content of waste grease to 
biodiesel  
To demonstrate the generality of this immobilization method, extracellular His-CALB 
(His-CALB) was also directly immobilized from cell culture supernatant of P. pastoris 
(h-CALB) with Ni-NTA-MNPs by using the same procedure described for His-TLL. 
The immobilization afforded nanobiocatalyst His-CALB-MNPs with a specific enzyme 
loading of 70 mg/g MNPs, 94% enzyme loading efficiency, a specific enzyme activity 
of 1.1 U/mg His-CALB (p-NPB assay), and 93% activity recovery (Table ‎3.1). Since 
CALB prefers esterification,
[122]
 His-CALB-MNPs was examined for the esterification 
of FFA of waste grease with methanol at 4.5 wt% catalyst loading (based on grease) 
and 30 °C for 12 h, providing 98% conversion of FFA. As it can be seen, the results for 
recycling and reusing His-CALB-MNPs for FFA conversion of waste grease are given 
in Figure ‎3.14.  
 
Figure ‎3.14. Recycling and reuse of His-CALB-MNPs for the esterification of FFA of waste 
grease with methanol. 
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His-CALB-MNPs were separated and then reused for the new cycle of the esterification 
of FFA, retaining 98% productivity in the 8
th
 cycle.  
3.4 Conclusion 
In summary, a simple and efficient method for the immobilization of extracellular 
enzyme without pre-purification was developed by using core-shell structured iron 
oxide magnetic nanoparticles Ni-NTA-MNPs containing long-armed Ni-NTA surface 
groups to simultaneously purify and immobilize target His-tagged enzyme directly 
from cell culture supernatant via affinity attachment. Ni-NTA-MNPs (63 nm) were 
synthesized in high yield (83%), and the use of these particles to immobilize His-TLL 
directly from the culture supernatant of P. pastoris (h-TLL) gave the corresponding 
magnetic nanobiocatalyst His-TLL-MNPs (80 nm) with high specific enzyme loading 
(62 mg/g MNPs), high enzyme loading efficiency (85%), and full enzyme activity 
recovery. Biotransformation of waste grease (containing 24 wt% FFA) with methanol 
using the nanobiocatalyst (5 wt% based on grease) afforded biodiesel in 94% yield. The 
nanobiocatalyst was easily recovered under magnet and exhibited excellent 
recyclability, retaining of 97% productivity in the 7
th
 cycle of biodiesel production. Ni-
NTA-MNPs were regenerable from the used biocatalyst and reusable for enzyme 
immobilization. The production of biodiesel from waste grease using the 
nanobiocatalyst is green, sustainable, high-yielding, and potentially practical. The 
immobilization method is generally useful for the immobilization of extracellular 
enzymes, as demonstrated by the efficient immobilization of extracellular His-CALB 
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from the cell culture supernatant of P. pastoris (His-CALB) as an active and recyclable 
nanobiocatalyst.  
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Chapter 4 Efficient synthesis of β-Pyrazol-1-
yl-L-alanine with Active and Recyclable O-
Acetylserine Sulfhydrylase-Immobilized 
Magnetic Nanobiocatalysts 
4.1 Introduction  
Amino acids are important precursors in preparation of pharmaceutical compounds.
[183]
 
Unnatural L-α-amino acids are able to add more chirality and complexity for naturally 
occurring amino acids; thus, it is of great interest to synthesize these amino acids. 
However, the chemical synthesis of these compounds is lengthy and consisting of 
unwanted byproducts and several reaction steps. The biotransformation of O-
acetylserine (OAS) with an appropriate nucleophile is a simple and green way to 
prepare L-α-amino acids.[148] O-acetylserine sulfhydrylase (OASS) CysK and CysM can 
catalyze this class of reactions with a broad range of substrates such as azides, thiols, 
and selonls.
[148]
 Therefore, several L-α-amino such as β-pyrazol-1-yl-L-alanine (PAA) 
can be produced through this approach. PAA has been found to be vital building blocks 








immunological or allergic disorders.
[189]
 The in vitro synthesis of PAA using OAS and 
pyrazole (PA) has clear advantages such as high yield and enantioselectivity compared 
to the chemical synthesis.
[190]
 Some reaserches have testified to the efficacy of OASS in 
the catalysis of O-acetylserine (OAS) to PAA through whole-cells
[148,152,153,191]




 However, for the whole-cell system, the lengthy reported 
fermentation processes (36-72 h) is generally time-consuming and for the free enzyme 
system, difficulties in purification of the enzyme from the whole-cell is complex and 
costly. Moreover, lack of recyclability for both systems can be considered as an 
obstacle for their applications. On the other hand, enzyme immobilization offers 
recycling and reusing of the biocatalyst, providing with more cost-efficient 
biotransformations. There are several methods for enzyme immobilization.
[18,171]
 With 
recent advancement in nanotechnology, the use of magnetic nanoparticles (MNPs) 
achieved greater focus in the field of enzymes immobilization since they exhibit 
advantageous properties such as high dispersibility, large surface area per volume, less 
mass transfer limitations, and simple magnetic separation.
[20,21,53,56,76,94,96,123,172]
 
However, most of the immobilization methods still require purified enzyme. Therefore, 
the first time immobilization of OASS CysK and CysM was investigated using 
simultaneous purification and immobilization of the His-tagged enzyme from the 
corresponding cell free extract (CFE) with Ni-NTA functionalized MNPs (Scheme ‎4.1). 
 
Scheme ‎4.1. Preparation of His-CysK-MNPs and His-CysM-MNPs from cell free extract of 
His-CysK and His-CysM. 
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4.2 Experimental section 
4.2.1 Chemicals, strains and plasmids 
N-acetylserine, O-acetylserine hydrochloride, pyrazole (98%), pyrazol-1-yl-alanine 
(95%),‎ pyridoxal‎ 5′-phosphate (98%), hydrochloric acid (37%) and ninhydrin were 
purchased from Sigma Aldrich. Monopotassium phosphate, dipotassium phosphate, 
phosphoric acid (85%) and acetic acid (100%) were purchased from Merck. 
Trifluoroacetic acid (99%) was purchased from Acros Organics. Kanamycin and 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) were purchased from Apollo Scientific 
and Gold Biotechnology, respectively. Gel electrophoresis equipment was purchased 
from Biorad. Loading dye GelPilot and PageRulerTM prestained protein ladder were 
purchased from Qiagen and Thermo Scientific respectively. Ni-NTA Agarose Resin 
(for purification of enzymes) was obtained from Roche Diagnostics GmbH. Amicon 
ultra-15 centrifugal tube (10 kDa) was purchased from Millipore. 
E. coli T 7 was purchased from New England Biolab and Plasmid pET 28a was 
obtained from Novagen. 
4.2.2 Analytical methods 
4.2.2.1 HPLC Assay 
The HPLC assay of OAS and NAS was established and performed using HPLC 
(Shimadzu) on poroshell 120, SB-Aq 2.7 μm (4.6 × 150 mm), mobile phase (100% 
dilute phosphoric acid) at a flow rate of 0.4 mL/min. The injection volume was 4 μL. 
The retention time of standard O-acetylserine (OAS) and N-acetylserine (NAS) were 
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3.80 and 4.71 min, respectively. The HPLC assay of PAA and PA was established and 
performed using HPLC (Shimadzu) on poroshell 120, EC-C18, 2.7 μm (4.6 × 150 mm), 
mobile phase containing 98% water and 2% acetonitrile (ACN) at a flow rate of 0.4 
mL/min. The injection volume was 4 μL. The retention times of PAA and PA were 6.04 
and 13.53 min, respectively. 
4.2.2.2 Enzymatic activity assay for OASS 
To determine the activity of the OASS CysM or CysK, first 270 µL solution containing 
0.11 mM PLP in 50 mM KP-buffer (pH 7.5) and 5 mM 2-mecarptoethanol was added 
into a 2mL reaction tube. Then 1 µL CFE (0.6 g protein/L) or immobilized enzyme 
suspension (dispersed in the reaction buffer and diluted 10 times to reach the 
concentration about 2 g/L) was added. Next, 15 µL sodium sulfide (20 mM) stock in 50 
mM NaOH and 15 µL OAS stock solution (200 mM in 200 mM KP-buffer, pH 4.5) 
were subsequently added into the tube. Also, the control sample was prepared by the 
same content as described above without addition of enzyme.  
Reactions were allowed to proceed at room temperature for 5 minute to generate L-
cysteine (sulfur based). After that, the reaction was stopped by addition of 150 µL 20% 
trifluoroacetic acid, 300 µL acetic acid and 600 µL ninhydrin reagent (1g in 40 mL 
acetic acid and HCl (37%) at 6:4 v/v), in sequence.  
Reaction mixture was heated at 98 °C for 10 minutes and then the mixture was placed 
in an ice box to cool down. The mixture was added into 1.8 mL of cold (0-4 °C) ethanol 
and mixed. The amount of L-cysteine product was analyzed with spectrophotometry 
machine at 560 nm wavelength.  
77 
4.2.3 Engineering of recombinant E. coli (CysK) or E. coli (CysM), cell growth, 
and enzyme expression 
4.2.3.1 Engineering of recombinant E. coli (CysK) or E. coli (CysM) 
O-acetylserine sulfhydrylase (OASS) cysK or cysM were amplified by PCR with 
following primers:  
cysK, F: GGAATTCCATATGAGTAAGATTTTTGAAGA Nde I and                          
R: CCGCTCGAGTTACTGTTGCAGTTCTTTCT Xho I; 
cysM, F: GGGAATTCCATATGAGTACATTAGAACAAACAAT Nde I and              
R: CCCAAGCTTAAATCCCCGCCCCCTGGCT Hind III, using genome from E. coli 
MG1655 as a template. The PCR products were inserted into plasmid pET28a between 
Nde I and Xho I or Nde I and Hind III to generate pET28a-CysK or pET28a-CysM, 
respectively. The generated plasmid was then transferred into E. coli T7 to form the 
strain E. coli T7 pET28a-CysK or E. coli T7 pET28a-CysM.  
4.2.3.2 Cell cultivation  
Mutant strains of recombinant E. coli T7 pET28a-CysK or E. coli T7 pET28a-CysM 
was grown on agar plates with kanamycin. A single colony was then inoculated into 2 
mL of LB medium (2% LB powder) with 50 μg/mL of kanamycin at 37 °C and 250 
rpm for 6 h. The culture seed was then transferred into 100 mL of autoclaved 2% LB 
medium (2 g LB, 1 g yeast in 100 mL DI water) with 50 μg/mL of kanamycin. Cell 
cultures were then grown in 500 mL conical flasks at 250 rpm until an optical density at 
600 nm (OD600) of 0.5–1 was reached within 2 hours. IPTG (gene expression inducer) 
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was then added at a final concentration of 1 mM (equivalent to 100 μL from 1 M stock 
solution). The temperature was switched to 22 °C for 15–16 h. 
4.2.3.3 Cell free extract preparation 
After reaching typically to OD600 of 8 at 14 h from induction, the cells were then 
harvested by centrifugation, while removing any supernatant. Cells were then washed 
with DI water at 5000 rpm for 10 minutes. Pellets were then re-suspended in 300 mM 
KP-buffer at pH 7.0 to a desired OD600 prior to use. 1 mL of cell suspension was then 
mixed with 0.5 mL of glass beads (0.1 mm diameter). Homogenization was then 
conducted for 3 cycles (2 minutes homogenization, 1 minute cooled in ice). Supernatant 
containing enzymes was obtained after centrifugation (13200 rpm for 10 minutes) for 
further utilization. 
4.2.4 Purification of His-CysM or His-CysK 
The purification of His-tagged enzymes was conducted using of a Ni-NTA agarose 
beads. The Ni-NTA agarose resin was first equilibrated with the equilibration buffer 
(20 mM KP-buffer at pH 7.5, 0.5 M NaCl) and then 1 mL was then mixed with 5-10 
equivalent mg of the as-harvested His-tagged enzymes for 2 h in a tube tumbler (30 
rpm room temperature). After 2 h, the suspension was poured into the column and it 
was first washed for 2 cycles using the wash buffer (20 mM KP-buffer, pH 7.5, 0.5 M 
NaCl, and 10 mM imidazole). Thereafter, the elution buffer (20 mM KP-buffer, pH 7.5, 
0.5 M NaCl, 300 mM imidazole) was added at 1 mL cycles in order to wash off His-
tagged enzymes. 2–3 mL of elution buffer was used to extract all proteins. The 
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imidazole was then removed by filter tube Amicon ultra-15 centrifugal tube (10 kDa) 
and the obtained enzyme was stored in 15% glycerol in freezer for further utilization. 
4.2.5 Synthesis of the Ni-NTA-MNPs 
The Ni-NTA-MNPs were synthesized following the reported procedure in section 3.2.6.  
4.2.6 Preparation of nanobiocatalyst (His-CysK-MNPs or His-CysM-MNPs) 
Simultaneous purification and immobilization of enzymes was conducted using 1 mL 
of CFE with variable protein concentration and 0.5 mL Ni-NTA-MNPs (32 g/L stock 
solution) using a tube tumbler at 30 rpm and room temperature for 2 h. After incubation, 
His-CysK-MNPs or His-CysM-MNPs were separated using magnet and washed once 
with buffer (300 mM KP-buffer at pH 7.0) and then resuspended into reaction buffer to 
a final volume of 1 mL. The amount of immobilized protein was determined via protein 
concentration in the supernatant before and after immobilization using Bradford reagent. 
4.2.7 Preparation of O-acetylserine substrate under mild neutralization 
The best neutralization method was established after testing different conditions of 
addition of sodium bicarbonate (data not shown). To prepare 2 M OAS solution, the 
required amount OAS.HCl powder was weighed in a tube and then sodium bicarbonate 
solution (2.2 M stock) was added dropwise into tub. The mixture was then vortexed and 
used within 5 minutes, making precautions to avoid the effervescence. The proposed 
method of neutralization using sodium bicarbonate has resulted in the delicate 
preservation of OAS content. 
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4.2.8 Synthesis of PAA  
4.2.8.1 Using cell free extract 
The biotransformation was conducted with 1 mL of CFE (6 g protein/L) in 300 mM of 
phosphate buffer (pH 7.0) containing 1.1 mM pyridoxal‎ 5′-phosphate (PLP). PA and 
OAS were then added at 2:1 molar ratio. Mixtures were incubated at 30 rpm (tube 
tumbler) and 35 °C. Samples (50 μL) were retrieved at time intervals of 10, 20, 30, 50, 
80, 120 minutes and quenched with 20 times (950 μL) dilute phosphoric acid (0.01%) 
and centrifuged at 12,000 rpm (10 minutes) for HPLC assay. 
4.2.8.2 Biotransformation with immobilized enzyme 
Biotransformation was conducted with immobilized His-CysK or CysM-MNPs (2.5 g 
immobilized enz./L and 3.0 g immobilized enz./L) in 300 mM of KP buffer (pH 7.0, 1.1 
mM PLP). First PA was added and then OAS was added with a given concentration (63, 
90, 122 mM) and an optimized molar ratio of 2:1 PA to OAS. Mixtures were incubated 
at 30 rpm (tube tumbler) and 35 °C for up-to 2 h. Samples (50 μL) were retrieved at 
time intervals of 10, 20, 30, 50, 80, 120 minutes and quenched with 20 times (950 μL) 
dilute phosphoric acid (0.01%) and centrifuged at 12,000 rpm (10 minutes) for HPLC 
assay. 
4.2.9 Recycling of the immobilized enzyme 
The recycling of His-CysK-MNPs was performed with 90 mM OAS and 2:1 molar 
ratio of PA to OAS. Each cycle of reaction was performed for 20 min. After separation 
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of nanobiocatalyst by using a magnet, new batch of substrates and preheated buffer was 
added to start new run of the biotransformation at the same conditions. 
4.2.10 Determining the enzyme leakage during recycling of nanobiocatalysts 
This set of experiments was conducted using immobilized His-CysK-MNPs (2.5 g 
enz/L) and His-CysM-MNPs 3.0 (g enz./L). The recycling of His-CysK-MNPs (90 mM 
OAS and 2:1 molar ratio of PA:OAS) and His-CysM-MNPs (63 mM OAS and 4:1 
molar ratio of  PA:OAS) experiments were conducted for 5 cycles and at 30 RPM (tube 
tumbler) and 35 °C for 20 min. The supernatant of biotransformation after separating 
the catalyst was characterized using Bradford reagent for each cycle to determine the 
protein content. 
4.2.11 Effect of substrates and product on the enzyme leakage 
To find out the impact of the substrates and product on protein bonding on the MNPs, 
the His-CysK-MNPs were incubated in 1 mL biotransformation buffer and a given 
reactant (PA (244 mM), OAS (63 mM) or PAA (50 mM)) separately at 30 rpm (tube 
tumbler) and 35 °C for 20 min. The catalyst was separated and the protein content of 
the supernatant was determined using Bradford reagent. 
4.2.12 Pretreatment of His-CysK-MNPs with β-pyrazol-1-yl-alanine (PAA) 
His-CysK-MNPs were incubated in 1 mL biotransformation buffer and 50 mM PAA at 
30 rpm (tube tumbler) and 35 °C for 20 min. Then the catalyst was separated by magnet 
and washed with buffer. This procedure was repeated for one more run. 
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The leaked enzyme amount was measured and the pretreated catalyst was adjusted to 
maintain 2.5 g immobilized enz./L (32 mg His-CysK-MNPs) for the recycling 
experiments and its performance was compared to the non-treated nanobiocatalyst (16 
mg His-CysK-MNPs, 2.5 g immobilized enz./L). 
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4.3 Results and discussion 
4.3.1 Engineering of the E. coli (His-CysK) and E. coli (His-CysM) and cell 
cultivation 
The OASS cysK and cysM genes containing His-tag were cloned and expressed in E. 
coli. The untagged CysM was also cloned. The cells were grown in LB medium, and it 
is displayed in Figure ‎4.1, the OD600 value of cells reached about 7. At this point, the 
cells were harvested and disrupted to give CFE. 
 
Figure ‎4.1. Growth curve of the recombinant E. coli (CysM) in LB medium. The protein 
induction was started by addition of IPTG with a final concentration of 1 mM at 2 h. 
The SDS-PAGE analysis (see Figure ‎4.2) revealed a high expression level of the target 
enzyme, His-CysM. The expression of His-CysM (35 kDa) seems to occur 2 h after 
addition of the IPTG as expression inducer at 2 h from the start of the cell cultivation. 
The high expression of the His-CysM was maintained after 6 h. 
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Figure ‎4.2. SDS-PAGE of His-CysM expression. Lane: 1, 2, 3, 4, and 5 are corresponding to 
cell free extract prepared from the cells harvested at 4, 6, 8, 10 and 12 h, respectively. Lane M 
is marker. 
4.3.2 Biotransformation of OAS and PA to synthesize PAA with CFE and purified 
His-CysM 
The harvested cell pellets after 14 h cultivation were resuspended in KP-buffer (300 
mM, pH 7.0). 0.5 mL of glass beads (0.1 mm diameter) was loaded into 1 mL of cell 
suspension and homogenization was then conducted for 3 cycles. The CFE of His-
CysM and untagged CysM was obtained after centrifugation and their activity were 
compared at 1.5 g protein/L loading for the synthesis of PAA from 122 mM OAS and 
244 mM PA in 2 h biotransformation time. As it can be observed from Figure ‎4.3, there 
were no observable differences between the His-tagged and untagged CysM for the 
preparation of PAA. His-tagged and untagged CysM gave 39 and 40 mM PAA, 
respectively, at 30 min and the increase in product concentration for both of the 
enzymes was consistent up to 120 min, achieving 60 and 61 mM PAA for His-tagged 
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and untagged CysM, respectively. This validated the selection of His-tagged enzyme 
for the further immobilization and biotransformation. The purification of His-CysM 
was conducted using commercial Ni-NTA agarose beads, and purified His-CysM was 
then tested for the biotransformation of the OAS and PA to PAA at the same conditions 
described for the CFE of untagged and His-tagged CysM. At the total protein 
concentration of 1.5 g/L, the purified His-CysM gave slightly higher product 
concentration, 67 mM PAA at 2 h, which is clearly due to the higher concentration of 
the His-CysM in the purified fraction. 
 
Figure ‎4.3. Time courses of the biotransformation of OAS (122 mM) and PA (244 mM) for the 
synthesis of PAA by CysM with a total protein concentration of 1.5 g protein/L. CFE of 
untagged CysM (), CFE of His-CysM (), and purified His-CysM (). Reactions were 
performed in KP-buffer (300 mM, pH 7.0, 1.1 mM PLP) at 35 °C. Data are the mean values of 
triplicated repeats. 
4.3.3 Simultaneous purification and immobilization of His-CysK and His-CysM 
with Ni-NTA-MNPs 
The Ni-NTA-MNPs were synthesized according to the reported procedure in Chapter 3. 
The CFE of His-CysK and His-CysM were treated with Ni-NTA-MNPs, respectively, 
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to immobilize enzymes without prepurification. By changing the protein concentration 
while using a fixed concentration of the MNPs (16 mg/mL), it was possible to prepare 
nanobiocatalysts with different specific enzyme loadings on the MNPs. As given in 
Table ‎4.1, at high protein concentration in the immobilization broth, 6 g/L, the highest 
specific enzyme loadings on the MNPs were achieved for both enzymes, corresponding 
to 150 and 190 mg enz./g MNPs for the His-CysK and His-CysM, respectively. By 
considering 16 mg of MNPs loading in 1 mL reaction buffer that we later employed for 
biotransformations, this afforded 2.4 g His-CysK/L and 3.0 g His-CysM/L enzyme 
concentration for the biotransformations. 

















His-CysM-MNPs 6.0 190±8 100±3 25±1.7 
His-CysK-MNPs 6.0 150±6 80±4 5±0.6 
a) Enzyme loading efficiency (%) was calculated on the basis of the total protein content before 
and after immobilization and 50% His-tagged enzyme content of CFE. b) Specific enzyme 
activity was determined using activity assay for the production of L-cysteine with sodium 
sulfide and O-acetylserine for 5 min at room temperature. 
For His-CysM-MNPs (190 mg His-CysM/g MNPs), the fraction of supernatant of CFE 
after immobilization, washing with 10 mM imidazole, and elution of the immobilized 
enzymes with 300 mM imidazole were analyzed by SDS-PAGE. As shown in 
Figure ‎4.4, the supernatant after immobilization contained no His-tagged enzymes.  
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Figure ‎4.4. SDS-PAGE analysis of His CysM-MNPs. Lane M: protein marker, Lane 1: 
supernatant after immobilization, and Lane2 and 3: elutes of consequent washing with 10 mM 
and 300 mM imidazole, respectively. 
The washed solution was also free of any His-tagged enzymes, and the elution buffer 
gave a clear His-CysM band at 35 kDa. This demonstrated the efficient immobilization 
of the His-CysM with Ni-NTA-MNPs. 
 
Figure ‎4.5. Representative TEM (inset) and FESEM images of His-CysM-MNPs. 
TEM images of the His-CysM in Figure ‎4.5, confirmed the core-shell structure and 
nano-size of His-CysM-MNPs with a size of 85 nm. FESEM was also captured, which 
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further confirmed the spherical shape and a narrow size distribution of the His-CysM-
MNPs. 
4.3.4 Biotransformation of OAS and PA to PAA with nanobiocatalysts His-CysM-
MNPs  
Synthesis of PAA using nanobiocatalysts, His-CysK-MNPs or His-CysM-MNPs, was 
examined. The overall biotransformation scheme using nanobiocatalyst is demonstrated 
in Scheme ‎4.2. 
 
Scheme ‎4.2. Synthesis of β-pyrazol-1-yl-alanine by His-CysK-MNPs or His-CysM-MNPs from 
O-acetylserine and pyrazole. 
For the His-CysM-MNPs, the biotransformations were conducted with 122 mM OAS 
and 244 mM PA at 0.8, 1.5 and 3.0 g/L of immobilized enzyme concentration. As it is 
shown in Figure ‎4.6, the impact of the immobilized His-CysM concentration up to 3.0 
g/L is very clear, specifically in the first 20 min of the biotransformation, affording 13, 
39, and 47 mM PAA at 0.8, 1.5, and 3.0 g immobilized His-CysM/L, respectively. The 
final PAA concentration at 120 min was also increased for the higher concentration of 
the immobilized His-CysM, providing 40, 61, and 80 mM PAA with 0.8, 1.5, and 3.0 g 
immobilized His-CysM/L, respectively. For the highest PAA concentration that was 
obtained with His-CysM-MNPs at 3.0 g His-CysM/L, it can be seen that almost 60% of 
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the final PAA (mM) was produced within first 20 min, which can be beneficial for 
recycling of this nanobiocatalyst in a short biotransformation time (20 min).  
 
Figure ‎4.6. Time courses of synthesis of PAA by using His-CysM-MNPs with protein 
concentrations: 0.8 g/L (), 1.5 g/L (), and 3.0 g/L (). The time course of CFE of His-
CysM at 6.0 g/L (×) is also given. All biotransformations were performed in KP-buffer (300 
mM, pH 7.0, 1.1 mM PLP) at 35 °C with 122 mM OAS and 244 mM PA. 
The use of CFE at 6.0 g protein/L (contained about 3.0 g His-CysM/L) gave 58 and 80 
mM PAA within 20 and 120 min, respectively, suggesting that the immobilized enzyme 
at 3.0 g immobilized His-CysM/L retained 81% of the enzyme activity in the CFE and 
could achieve the same product concentrations after 80 min of the reaction time. 
Also, the performance of His-CysM-MNPs was compared with the purified His-CysM 
at 1.5 g enz./L (Figure ‎4.3). Although His-CysM-MNPs (Figure ‎4.6) gave 70% of the 
initial activity (first 10 min) of the purified enzymes, it reached 90% of the performance 
of the purified His-CysM during the reaction. This indicated the immobilized enzyme 
retained high enzyme activity during the biotransformation. 
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The chromatograms of the substrates and product (PAA) analyzed by HPLC are given 
in Figure ‎4.7.  
 
Figure ‎4.7. HPLC chromatograms of: a) OAS and NAS analyzed by poreshel-120 SB-Aq 




4.3.5 Biotransformation of OAS and PA to synthesize PAA with nanobiocatalysts 
His-CysK-MNPs  
 
Figure ‎4.8. Time courses of the synthesis of PAA by His-CysK-MNPs with 2.4 g/L 
immobilized protein concentration. Addition of variant OAS and PA (with a constant molar 
ratio of 2:1 PA to OAS) was performed: 63 mM OAS (), 90 mM OAS () and 122 mM 
OAS (). The time course of PAA production of CFE of 6 g/L His-CysK () with 122 mM 
OAS and 244 mM PA is also given. Reactions were performed in KP-buffer (300 mM, pH 7.0, 
1.1 mM PLP) at 35 °C. 
The performance of the His-CysK-MNPs with specific enzyme loading of 150 mg/g 
MNPs (corresponding to 2.4 g/L) was also investigated to increase in the product 
concentration and compare its activity to His-CysM (Figure ‎4.8). With initial 122 mM 
OAS concentration, His-CysK-MNPs gave 65 mM PAA at 20 min while His-CysM-
MNPs (3.0 g/L) produced 47 mM. This clearly shows the His-CysK-MNPs have a 
higher initial activity compared with His-CysM-MNPs. His-CysK-MNPs at 2.4 g 
enz./L also afforded a slightly higher final PAA concentration, giving 85 mM PAA 
compared with 80 mM PAA that obtained from His-CysM-MNPs at 3.0 g enz./L. For 
the lower OAS concentrations, the His-CysK-MNPs almost reached to the maximum 
conversion within only 20 minutes. At the initial concentrations of 122 and 90 mM 
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OAS, the same product concentration was obtained (65 mM). Therefore, 90 mM OAS 
was chosen for the recycling of His-CysK-MNPs to reach high product concentration in 
each cycle. 
4.3.6 Recycling and reuse of the nanobiocatalyst His-CysM-MNPs for the synthesis 
of PAA 
Having confirmed that 3.0 g His-CysM/L concentration of the immobilized enzymes 
would bring a rapid initial reaction and high final product concentration, the 
recyclability of the prepared nanobiocatalysts were tested and analyzed and product 
concentrations in each cycle are given in Figure ‎4.9. 
His-CysM-MNPs were used for the purpose of analyzing its recyclability for 10 cycles 
with two different approaches of substrates addition. In first approach, the substrates 
were added as 122 mM OAS and 244 mM PA and the first cycle produced 50 mM PAA. 
A gradual drop in the product concentration was then noted; where a product 
concentration of only about 24 mM PAA was achieved from the same reaction 
conditions by the 10
th
 cycle. 
Summing the total product concentration of all ten cycles and considering 1 mL 
reaction volume for each cycle, the formation of 342 µmoles PAA from 1220 µmoles 
OAS, retained 48% productivity. However, due to the low overall conversion of 28%, 
another approach for the addition of substrates was applied for the recycling of His-
CysM-MNPs. Therefore, second approach set to be at the same biotransformation 
conditions but with addition of 63 and 252 mM OAS and PA, respectively. 
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Figure ‎4.9. Product concentration (mM) in each cycle of recycling His-CysM-MNPs (3.0 g 
enzyme/L) with different substrate addition approaches. 
The initial performance of the His-CysM-MNPs was similar to the conditions utilizing 
higher OAS concentration, achieving 50 mM PAA in the first cycle. Product 
concentration was gradually dropped in each cycle, where a conversion of only about 
27 mM PAA was achieved by the 10
th
 cycle. This gave 54% productivity retention in 
the tenth cycle. After 10 cycles, the total formation of 392 µmoles PAA afforded an 
overall conversion of 62%. Hence, addition of the 63 mM OAS (with 4:1 molar ratio of 
PA to OAS) could produce even slightly more product and provide more than double 
overall conversion. 
4.3.7  Recycling and reuse of the nanobiocatalyst His-CysK-MNPs for the 
synthesis of PAA 
The His-CysK-MNPs were recycled for PAA production in predetermined optimized 
conditions with initial concentration of OAS and PA of 90 and 180 mM, respectively. 
As it is shown in Figure ‎4.10, this system gave 67 mM PAA in the first cycle and 38 
mM by the 10
th
 cycle. The total production of PAA reached 470 µmoles (1 mL reaction 
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volume for each cycle) from 900 µmoles OAS, affording 52% overall conversion. Even 
though this overall conversion of His-CysK-MNPs is lower than the second recycling 
system for His-CysM-MNPs (62%, with 63 mM OAS in each cycle), the productivity 
retention (57%) and total product were higher than His-CysM-MNPs after 10 cycles 
and also less PA was used in each cycle (180 mM instead of 252 mM). 
 
Figure ‎4.10. Product concentration (mM) for each cycle of recycling non-treated His-CysK-
MNPs (2.4 g enzyme/L) using 90 mM OAS and 180 mM PA for 20 min at 35 °C. 
4.3.8 Investigation the possible enzyme leakage during the nanobiocatalyst 
recycling   
The recycling pattern of His-CysK-MNPs was similar to His-CysM-MNPs system, with 
a decline in the product concentration after first and second cycles.  
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Figure ‎4.11. Enzyme leakage during the recycling of His-CysK-MNPs () and His-CysM-
MNPs (). 
Therefore, the enzyme leakage from His-CysK/CysM-MNPs was determined during 
the recycling of these nanobiocatalysts. As can be seen in Figure ‎4.11, there is a 
significant enzyme leakage for both nanobiocatalysts in the first cycle and this leakage 
was decreased to as little‎as‎ ‎0.07 mg/mL in the 5th cycle. This can explain the decline 
in the productivity of the nanobiocatalysts during the recycling specially after 2 cycles.  
To find out the possible causes of the enzyme leakage, the impact of the substrates and 
product on the protein leakage was investigated individually (Figure ‎4.12).  
 
Figure ‎4.12. Effect of different reagents on the immobilized enzyme for the nanobiocatalyst 
His-CysM-MNPs. OAS, PA and PAA were added in 63, 244 and 50 mM in the reaction buffer. 
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It was found that the product (PAA) can elute a portion of the immobilized His-CysK 
or His-CysM in the first cycle, which this leaked enzyme portion can be attributed to 
those enzymes with a weaker affinity bonding to the Ni-NTA functions. The enzyme 
leakage is probably due to the similar chemical structure of PAA and His-tag; hence, 
PAA molecules could replace the weakly bonded His-tagged enzymes. 
4.3.9 Recycling of the pretreated His-CysK-MNPs for the biotransformation of 
OAS and PA to PAA 
As a solution His-CysK-MNPs were first pretreated with 50 mM PAA (in 1 mL of 
reaction buffer and reaction conditions) then used for recycling experiments. The initial 
protein concentration was kept at approximately 2.4 g/L by using 32 mg pretreated His-
CysK-MNPs.  
 
Figure ‎4.13. Product concentration (mM) in each cycle of recycling pretreated and non-treated 
His-CysK-MNPs (2.4 g enzyme/L) with 90 mM OAS and 180 mM PA for 20 min at 35 °C. 
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As it is displayed in Figure ‎4.13, the concentration of product in each cycle was 
considerably higher and stable compared to the non-treated His-CysK-MNPs. This 
system could afford 69 and 53 mM PAA in the first and 10
th
 cycle, respectively. Also, 
the overall product amount after 10 cycles was significantly higher than other systems 
achieving 626 µmoles from 900 µmoles OAS with an overall conversion of 70%. Since 
the pretreated His-CysK-MNPs exhibited high stability, the nanobiocatalyst was 
recycled for 20 cycles, affording 43 mM PAA with a total PAA of 1080 µmole and 
retaining 62% of the productivity in the twentieth cycle. The detailed results and 
comparasion between two nanobiocatalysts are given in Table ‎4.2.  




























122 244 3.0  50 24 48 28 342  
His-CysM-
MNPs 
63 252 3.0  50 27 54 62 392  
His-CysK-
MNPs 





90 180 2.4  69 53 77 60d 1080  
The biotransformations were performed with 16 mg nanobiocatalyst loading in 1 mL reaction 
volume for 20 min at 35 °C. a) Productivity was calculated on the basis of product 
concentrations in the tenth and first cycles. b) Overal conversion was calculated from the total 
PA produced (µmoles) and the total OAS (µmoles) used. c) Pretreated His-CysK-MNPs. d) 
Obtained from product concentration in the twentieth cycle. 
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4.4 Conclusion 
In this study, the practicality of using His-tagged OASS was confirmed by 
demonstrating the same activity of the untagged and His-tagged CysM, achieving 61 
and 60 mM PAA at 120 min, respectively, from 122 mM OAS and 244 mM PA using 
1.5 g protein/L CFE. The use of immobilized His-tagged OASS CysK and CysM in the 
biotransformation of OAS and PA to PAA were demonstrated. The successful 
simultaneous purification and immobilization of His-CysK and CysM from CFE using 
Ni-NTA-MNPs was presented and it gave 190 mg His-CysM/g MNPs and 150 mg His-
CysK/g MNPs. Performing the biotransformation of 122 mM OAS and 244 mM needed 
3.0 g His-CysM/L immobilized enzyme concentration at the optimal design and His-
CysM-MNPs achieved 47 and 80 mM PAA at 20 and 120 min, respectively. For His-
CysK-MNPs at a relatively lower enzyme concentration of 2.4 g/L, a higher product 
concentration of 67 mM PAA obtained from 90 mM OAS and 180 mM, which 
indicated the higher specific activity of His-CysK towards PA. 
The recycling experiments were conducted for His-CysM-MNPs, using variable 
substrate concentrations, which the best results for this nanobiocatalyst was obtained by 
adding 63 mM OAS and 252 mM PA in each cycle, giving 62% overall conversion 
(from the 63 mM OAS and 252 mM PA in each cycle) and retaining 54% productivity 
by the 10
th
 cycle. Also, His-CysK-MNPs reached 52% overall conversion (from 90 mM 
OAS and 180 mM PA in each cycle), retaining 57% activity after 10 cycles. The drop 
in the productivity, specifically after first 2 cycles, was observed and studied. It was 
found that the pretreatment of His-CysK-MNPs with PAA could wash out the weakly 
bonded His-tagged enzyme. The immobilized enzyme concentration after pretreatment 
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was adjusted to 2.4 g enz./L by using approximately 32 mg pretreated His-CysK-MNPs 
and  provided highly stable nanobiocatalysts, achieving overall conversion of 63% after 
20 cycles from 90 mM OAS and 180 mM PA in each cycle. This study presents the 
pioneering investigation of the preparing immobilized CysK and CysM via simple 
simultaneous purification and immobilization of His-CysK and His-CysM as highly 
active and recyclable nanobiocatalysts. The biotransformation of OAS and PA into 
PAA through the recycling of nanobiocatalyst is a very fast and productive way and 




Chapter 5 Synthesis of S-Substituted L-
Cysteines via Sulfhydrylation of O-acetylserine 
by O-acetylserine Sulfhydrylase CysM using 
Substituted Arylthiols and Benzylthiol 
5.1 Introduction 
The importance of the amino acids as pharmaceutical intermediates is greatly 
understood and their synthesis and applications has attracted much attention.
[5,25,148,183]
 
The unnatural amino acids introduce a strong tool to prepare new drug intermediates 
leading to the new activity and functionality of the target drugs. The chirality of these 
drug intermediates is very crucial since using racemic compounds leads to unwanted 
side effects but chiral compounds exhibit certain chemical properties providing more 
active and useful drugs. To prepare different unnatural amino acids, several chemical 
synthesis approaches have been reported.
[193,194]
 However, these methods mostly lack 
enantioselectivity to give the final chiral product and need resolution steps, which 
might be inefficient or not applicable for some compounds. On the other hand, 
biocatalytic synthesis of unnatural amino acids offers enantioselective preparation of 
these compounds.
[25,195]
 S-aryl-L-cysteines are a group of unnatural amino acids and S-
phenyl-L-cysteine belongs to this group of compounds, which is used for the synthesis 
of a HIV protease inhibitor.
[160]
 For the chemical synthesis of S-arylcysteines, aside 
from non-selective synthesis method,
[193]
 the enantioselective approach suffers from 
multi-step reactions including protection and deprotection of functional groups, toxic or 
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corrosive utilization and by-products.
[196]
 Although the enzymatic synthesis of the S-
phenyl-L-cysteine is reported,
[148,197,198]
 they have only demonstrated synthesis of a very 
limited number of S-arylcysteines. It is known that O-acetylserine sulfhydrylase CysM 
shows activity towards O-acetylserine and arylthiols to produce S-arylcysteines in a 
simple and green process. Nevertheless, its activity and possible selectivity towards the 
substituted arylthiols is not known. The importance of the S-aryl-L-cysteines as active 
pharmaceutical ingredients and the limited studies on the substrate specificity of OASS 
CysM is a great motivation to expand the research in this area. Here, the use of free 
CysM to explore its activity and selectivity towards arylthiols (2-, 3-, or 4-substituted 
thiophenols and benzyl mercaptan) for the synthesis of S-aryl-L-cysteines is aimed. 
Moreover, to achieve a higher productivity through the biocatalyst recycling, His-CysM 
is simultaneously purified and immobilized on the MNPs with Co-NTA functions. The 
activity of this nanobiocatalyst and His-CysM-Ni-MNPs (from Chapter 4) for these 
biotransformations is compared with the free enzyme system and the recyclability of 
these nanobiocatalysts is also investigated. This study may help to understand the 
catalytic performance of OASS CysM for the synthesis S-arylcysteines more in depth 
and provide a highly productive process benefiting active and recyclable 
nanobiocatalysts. 
5.2 Experimental section 
5.2.1 Chemicals, strains and plasmids 
O-acetylserine hydrochloride, N-acetylserine (9 %),‎ pyridoxal‎ 5′-phosphate (98%), 
hydrochloric acid (37%), acetic acid (100%), trifluoroacetic acid (99%), Cobalt(II) 
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chloride, S-benzyl-L-cysteine (97%), and ninhydrin were purchased from Sigma-
Aldrich. Benzyl mercaptan (96%), 4-acetamidobenzenethiol (95%), 4-mercaptobenzoic 
acid (95%), 3-aminobenzenethiol (97%), 2-aminobenzenethiol (95%), 2-
hydroxybenzenethiol (97%), 3-hydroxybenzenethiol (98%), and 4-hydroxybenzenethiol 
(95%) were purchased from TCI. Acetic acid-d4 was purchased from Cambridge 
Isotope Laboratories. Dipotassium phosphate, monopotassium phosphate, and 
phosphoric acid (85%) were purchased from Merck. Acetonitrile and ethanol (HPLC 
grade) were purchased from Tedia. Amicon ultra centrifugal tube (10 kDa) was 
purchased from Millipore. 
E. coli T 7 was obtained from New England Biolab. Plasmid pET 28a was purchased 
from Novagen. 
5.2.2 Analytical methods 
5.2.2.1 HPLC Assay 
The analysis of OAS and NAS was conducted using HPLC(Agilent) assay on poroshell 
120, SB-Aq 2.7 μm (4.6 × 150 mm) column and 100% diluted phosphoric acid (0.1 mL 
in 1 L ultrapure water) mobile phase at a flow rate of 0.4 mL/min with an injection 
volume of 5 μL. The retention time of the OAS and N-acetylserine (NAS) were 3.29 
and 4.31 min, respectively. The HPLC assay of S-benzyl-L-cysteine was established 
and performed by HPLC (Agilent) on poroshell 120, EC-C18, 2.7 μm (4.6 × 150 mm) 
column with mobile phase of 50% potassium phosphate buffer (20 mM, pH 2.5) and 
ACN (50:50, v/v) with a flow rate of 0.4 mL/min and 4 μL injection volume at 210 nm 
UV detection. The retention time of S-benzyl-L-ysteine was 3.56 min. 
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5.2.2.2 Nuclear magnetic resonance (NMR) 
The isolated products from biotransformations were dried in a vacuum oven at r.t. for 
24 h. The sample for the NMR was prepared with 2 mg of the dried product dissolved 
in 1 mL D2O with 2% v/v acetic acid-d4. The spectra were recorded on a Bruker 
Instruments, Inc. DRX500 and AMX500 spectrometer at 500 MHz and 126 MHz for 
1
H NMR and 
13
C NMR, respectively. Chemical shifts in ppm were referred to 
tetramethylsilane at 0.00 ppm. 
5.2.2.3 Energy dispersive X-ray spectroscopy (EDX) 
The EDX spectra were recorded for element analysis. 15 μL of the desired particle 
solution was air-dried on a cupper belt and analyzed by Oxford Instruments INCAx-act. 
5.2.2.4 Vibrating sample magnetometer (VSM) 
The VSM measurement was performed using a LakeShore 7404 at room temperature. 
The freeze-dried powder of the desired sample was used for the VSM measurements. 
The vibration distances were recorded by changing the strength of electronic field from 
-10000 to 10000 Oe. 
5.2.2.5 Enzymatic activity assay for OASS 
The activity of the enzyme in the form of free or immobilized was determined by using 
the activity assay as described in section 4.2.2.5. 
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5.2.3 Engineering of recombinant E. coli (CysM), cell growth, and enzyme 
expression 
5.2.3.1 Engineering of recombinant E. coli (CysM) 
The engineering procedure for the recombinant E. coli (CysM) is described in section 
4.2.3.  
5.2.3.2 Cell cultivation  
Mutant strains of recombinant E. coli T7 pET28a-CysM was grown on an agar plate 
containing 50 μg/mL of kanamycin. A single colony was then inoculated into 2 mL of 
LB medium (2% LB powder) with 50 μg/mL of kanamycin at 37 °C and 250 rpm for 6 
h. The culture seed was then transferred into 100 mL of autoclaved 2% TB medium in 
500 mL conical flasks with 50 μg/mL of kanamycin. The cells were grown at 250 rpm 
until an OD600 of 0.5 was reached within 2 hours. At that point, IPTG was added at a 
final concentration of 1 mM (equivalent to 100 μL from 1 M stock solution). The 
temperature was switched to 22 °C and cells were continued growing for 15 h and 
could reach OD600 16–18. 
5.2.3.3 Cell free extract preparation 
Cells were harvested and washed twice with KP buffer (10 mM, pH 8.0). After that, the 
cell suspension with used for the cell disruption by passing through a homogenizer 
twice at 21 psi. The cell debris was centrifuged at 4 °C and 12000 rpm 10 min. 
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5.2.4 Purification of His-CysM 
The purification of His-tagged OASS CysM was conducted with FPLC (AKTA purifier 
system) with a Ni-NTA column (HisPrep FF 16/10 column) at 4 °C. The purification 
was performed in FPLC with one chromatography column and the purification progress 
was monitored online by absorption of total protein at 280 nm. The column was washed 
and balanced with 120 mL of 10 mM imidazole (from 300 mM stock with an adjusted 
pH of 7.4) and sodium phosphate buffer (20 mM, pH 7.4) containing 0.5 M NaCl. 100 
mL CFE was loaded into the column and washed with 60 mL of 30 mM imidazole (300 
mM stock was adjusted with buffer) to eliminate the non-specific bondings. The His-
CysM was then eluted with 300 mM imidazole (30 ml). The elution fractions were 
concentrated and washed (3 × 20 mL of KP buffer 10 mM, pH 7.5) by 10 kDa ultra 
centrifugal filter tubes to remove imidazole and finally combined for the 
biotransformations experiments. 
5.2.5 Synthesis of the Co-NTA-MNPs 
The Ni-NTA-MNPs were synthesized following the reported procedure in section 3.2.6. 
The Co(II)-NTA-MNPs were synthesized from NTA-MNPs (from a same procedure as 
described above) with addition of 1 mL Co(II) chloride (1M) into the 20 mL of NTA-
MNPs (∼400 mg) under 600 rpm stirring speed and r.t. After 2 h, the reaction was 
stopped and the Co(II)-NTA-MNPs were collected with a magnet and washed with DI 
water for further use. 
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5.2.6 Preparation of nanobiocatalysts His-CysM-Ni-MNPs and His-CysM-Co-
MNPs 
Simultaneous purification and immobilization of His-CysM was conducted using 0.55 
mL of CFE at 4.1 g protein/L and 0.45 mL Ni-NTA-MNPs or Co-NTA-MNPs (36 
mg/mL stock solution). The samples were shaken using a tube tumbler at 30 rpm and r.t. 
for 2 h. After shaking, His-CysM-Ni-MNPs or His-CysM-Co-MNPs were separated 
using magnet and washed (2 × 1 mL) with KP buffer (300 mM, pH 7.0) and then 
resuspended into 1 mL reaction buffer (contained 1.1 mM PLP). The amount of 
immobilized protein was determined through the protein concentration measurements 
in the supernatant before and after immobilization by Bradford reagent. 
5.2.7 Synthesis of S-benzyl-L-cysteine with CFE of His-CysM 
The biotransformation was conducted with 1 mL CFE in KP buffer (300 mM, pH 7.0) 
containing 1 mM PLP. 0.08–0.23 mmol (8.9–27 μL) benzyl mercaptan (15) was added 
to the reaction tube and the reaction was started after addition of freshly prepared OAS 
(2M, neutralized by 2.2 M bicarbonate sodium) at 1.2:1 molar ratio of 15 to OAS. 
Mixtures were incubated at 30 rpm (tube tumbler) and 35 °C for up to 2 h. Aliquots (50 
μL) were retrieved for OAS and NAS analysis at time intervals of 10, 30, 60 min and 
quenched with 20 times (950 μL) dilute phosphoric acid (0.01%) and centrifuged at 
15,000 rpm for 5 min before injection into HPLC. The product (16) analysis at desired 
time points was performed by addition of 0.5 M HCl into reaction tube to stop the 
reaction and dissolve the product. The samples were further diluted (final dilution of 50 
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X) in the buffer (potassium phosphate 20 mM, pH 2.5), centrifuged 15,000 rpm for 5 
min and supernatant was injected into the HPLC for analysis.  
Product 16 (isolated yield 80%): 
1
H NMR (D2O with 2% v/v acetic acid-d4, 500 MHz): 
δ 7.33 – 7.26 (4H, m), 7.22 (1H, ddt, J=8.6, 5.7, 2.9 Hz), 3.75 (1H, dd, J=7.6, 4.4 Hz), 
3.70 (2H, s), 2.91 (1H, dd, J=14.8, 4.4 Hz), 2.82 (1H, dd, J=14.8, 7.6 Hz). 
13
C NMR 
(D2O with 2% v/v acetic acid-d4, 126 MHz): δ 172.66, 138.15, 129.25, 129.16, 127.79, 
53.54, 35.55, 31.64. 
5.2.8 Synthesis of S-arylcysteines with free or immobilized His-CysM form O-
actylserine and arylthiols 
Biotransformations were conducted with 1.0 and 2.0 g enz./L free His-CysM or 16 mg 
nanobiocatalysts, His-CysM-Ni-MNPs (1.8 g enz./L) and His-CysM-Co-MNPs (2.0 g 
enz./L), in 1 mL KP buffer (300 mM, pH 7.0 containing 1 mM PLP). First the desired 
arylthiol (0.12 mmol) was added into the reaction tube and then 0.10 mmol OAS (2M) 
was added to start the biotransformation. Mixtures were shaken with a tube tumbler at 
30 rpm and 35 °C for 1 h. Samples (50 μL) were retrieved at time intervals of 20, 40, 60 
min and quenched into the 950 μL of diluted phosphoric acid (0.01%) and centrifuged 
at 12,000 rpm for 10 minutes before HPLC analysis. 
Product 2 (isolated yield of 90%), 
1
H NMR (D2O with 2% v/v acetic acid-d4, 500 MHz): 
δ 7.47 (1H, dd, J=7.8, 1.5 Hz), 7.22 (1H, td, J=7.7, 1.5 Hz), 6.90 – 7.03 (2H, m), 3.70 
(1H, dd, J=7.2, 4.3 Hz), 3.25 (1H, dd, J=14.7, 4.4 Hz), 3.17 (1H, dd, J=14.7, 7.2 Hz). 
13
C NMR (D2O with 2% v/v acetic acid-d4, 126 MHz): δ 172.37, 143.73, 136.03, 
130.92, 123.19, 119.98, 119.03, 53.94, 36.20. 
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Product 4 (isolated yield of 50%), 
1
H NMR (D2O with 2% v/v acetic acid-d4, 500 
MHz): δ 7.28 – 7.38 (2H, m), 7.24 (1H, t, J=1.9 Hz), 7.06 (1H, dq, J=7.3, 2.4, 2.0 Hz), 
3.78 (1H, dd, J=8.0, 3.9 Hz), 3.53 (1H, dd, J=15.1, 4.0 Hz), 3.29 (1H, dd, J=15.1, 8.0 
Hz). 
13
C NMR (D2O with 2% v/v acetic acid-d4, 126 MHz): δ. 172.20, 135.22, 130.79, 
127.98, 122.37, 120.01, 53.48, 34.50. 
Product 12 (isolated yield of 24%), 
1
H NMR (D2O with 2% v/v acetic acid-d4, 500 
MHz): δ 7.80 (2H, dd, J=49.8, 8.3 Hz), 7.37 (2H, dd, J=67.4, 8.4 Hz), 3.87 (1H, dd, 
J=8.4, 3.9 Hz), 3.51 (1H, q, J=7.1 Hz), 3.29 – 3.36 (1H, m). 
Product 14 (isolated yield of 65%), 
1
H NMR (D2O with 2% v/v acetic acid-d4, 500 
MHz): δ 7.35 – 7.44 (2H, m), 7.26 – 7.34 (2H, m), 3.75 (1H, dd, J=8.3, 3.9 Hz), 3.45 
(1H, dd, J=15.0, 3.9 Hz), 3.20 (1H, dd, J=15.0, 8.3 Hz), 2.03 (3H, s). 
13
C NMR (D2O 
with 2% v/v acetic acid-d4, 126 MHz): δ 173.21, 172.22, 136.96, 132.35, 129.09, 
122.81, 53.52, 35.52, 23.11. 
5.2.9 Recycling and reuse of the nanobiocatalysts His-CysM-Ni-MNPs and His-
CysM-Co-MNPs 
16 mg nanobiocatalysts His-CysM-Ni-MNPs (1.8 g enz./L) and His-CysM-Co-MNPs 
(2.0 g enz./L) were loaded into reaction buffer with 120 mM BM and 100 mM OAS 
and were shaken using a tube tumbler at 30 rpm and 35 °C for 40 min. After that, the 
nanobiocatalysts were separated by a magnet and washed with buffer (1 × 1 mL). These 
nanobiocatalysts were reused for the new batch of biotransformation in the preheated 
buffer solution at the same conditions as described above.  
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5.3 Results and Discussion 
5.3.1 Syntheis of S-arylcysteines with free His-CysM from OAS and arythiols 
The arylthiols with hydroxyl, amide, carboxyl, and acetamido substitutes as well as 
benzyl mercaptan were examined for the synthesis of S-arylcysteine with OAS using 
His-CysM. The overall reaction scheme is elaborated in Scheme ‎5.1. To synthesize 
these unnatural amino acids from arylthiols, both free and immobilized His-CysM 
systems were assessed and their activity was compared. 
 
Scheme ‎5.1. Synthesis of S-arylcysteines from arylthiols and O-acetylserine using free O-
acetylserine sulfhydrylase CysM or the immobilized enzymes on the Ni-NTA-MNPs or Co-
NTA-MNPs from. 
CFE of His-CysM (3.0 g protein/L) was simply used to study the optimal initial OAS 
concentration with a fixed 1:1.2 molar ratio of OAS to arylthiol using His-CysM in the 
synthesis of S-arylcysteines, choosing the synthesis of 16 as the model 
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biotransformation. The time courses of these biotransformations for the product (16) 
concentration and OAS conversion are given in Figure ‎5.1. The conversion of OAS to 
16 was 79% and 72% corresponding to 50 and 72 mM 16 for the initial 63 and 100 mM 
OAS at 60 min, respectively. However, a further increase in the initial OAS 
concentration to 190 mM did not significantly improve the product concentration and 
only gave 78 mM 16 and 41% OAS conversion.  
 
Figure ‎5.1. Time courses of biotransformations of OAS and 15 at 1:1.2 molar ratio for the 
synthesis of 16 using CFE of His-CysM (3.0 g protein /L) in 300 mM KP buffer pH 7.0 
containing 1.1 mM PLP at 30 rpm and 35 °C for 1 h. a) Concentration (mM) of the 16 versus 
time with 63 (), 100 (), and 190 mM () initial OAS. b) OAS conversion (%) with 63 (), 
100 (), and 190 mM () initial OAS.  
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Although the product concentration (78 mM 16) for the 190 mM initial OAS was 
slightly higher than 100 mM OAS, the OAS conversion to product was remarkably 
dropped to 41%. These results indicate that His-CysM catalyzes the biotransformation 
efficiently with up to 100 mM initial OAS but OAS conversion decreased after that, 
suggesting the initial 100 mM OAS is the optimal concentration for the rest of the 
biotransformations. 
Table ‎5.1. Synthesis of S-arylcysteines from OAS and 2-, 3- or 4-substituted arylthiols and 
benzyl mercaptan by free His-CysM.   
Entry Substrate 
a 
Enzyme conc. (g/L) Product Yield (%) 
b 
1 1 2.0 2 96 
2 3 2.0 4 79 
3 5 2.0 6 - 
4 7 2.0 8 62 
5 9 2.0 10 - 
6 11 2.0 12 27 
7 13 2.0 14 73 
8 15c 2.0 16 88 
9 3 1.0 4 57 
10 7 1.0 8 53 
11 11 1.0 12 17 
12 13 1.0 14 53 
13 15 1.0 16 44 
a) Biotransformations were carried out with 100 mM O-acetylserine and 120 mM arylthiol 
substrates in 1 mL of free His-CysM (with a specified concentration) in KP buffer (300 mM, 
pH 7.0 containing 1.1 mM PLP) using a tube tumbler at 30 rpm and 35 °C for 1 h. b) 
Determined by HPLC analysis on the basis of the conversion of the OAS to product. c) The 
reaction was completed at 40 min. 
 
The S-arylcysteines synthesized by free His-CysM are listed in Table ‎5.1. At 2.0 g His-
CysM/L showed the highest activity towards substrates 1 and 15 affording 96% and 
88% of 2 and 16, respectively. The activity was also significantly high for substrates 3 
and 13 giving 79% and 73% yield of S-arylcysteines 4 and 14, respectively. For the 
substrate 11 with 4-carboxyl substitution, the product 12 yield could only reach 27%. 
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Surprisingly, the CysM exhibited a unique regioselectivity of hydroxyl substitutions 
(Table ‎5.1, entries 3–5), affording 8 in 62% yield form 3-hydroxyl substituted 
thiophenol (7) but no product was formed from 2- or 4-hydroxyl substitution (substrates 
5 and 9, respectively). Also, it can be seen that CysM enzyme for the substrates 1 and 3 
with 2- and 3-amide substitutions, respectively, provided higher product yields than 
substrate 7. Therefore, these results revealed that the substrate specificity of the CysM 
for the substituted arylthiols follows the sequence of amide > acetamido > 3-hydroxyl > 
carboxyl. In overall, the use of 1.0 g/L His-CysM enzyme (Table ‎5.1, entries 9–13) for 
substrates 3, 7, 11, 13, and 15 resulted lower yields of the products 4, 8, 12, 14 and 16, 
respectively, compared to the corresponding biotransformations with  2.0 g /L His-
CysM. 
5.3.2 Simultaneous purification and immobilization of the His-CysM from CFE 
using Ni-NTA-MNPs or Co-NTA-MNPs  
The Ni-NTA-MNPs were synthesized as described in Chapter 3. To further study the 
possible impact of metal ion on the stability of the attached His-tagged enzyme to that 
metal-chelate function, the Co(II) was introduced to the NTA-MNPs. The NTA-MNPs 
were synthesized as it is described before, and then treated with Co(II) chloride solution. 
The obtained Co-NTA-MNPs were separated from the reaction mixture by a magnet 
and washed with DI water and used for enzyme immobilization. 
His-CysM was immobilized on the Ni-NTA and Co-NTA functionalized MNPs. These 
two nanocarriers showed a similar performance in the simultaneous purification and 
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immobilization of His-CysM from CFE, with Co-NTA-MNPs showing slightly better 
performance. 






















4.1 125±5 97±4 21.0 ± 1.5 89 
His-CysM-Ni-
MNPs 
4.1 110±5 91±3 21.1±1.1 90 
a) Enzyme loading efficiency (%) was calculated on the basis of CFE contains 50 % His-CysM, 
which was obtained from purification by FPLC. b) Activity was determined using L-cysteine 
production assay at room temperature for 5 min. 
The key performance data from simultaneous purification and immobilization of the 
His-CysM are listed in Table ‎5.2. For the Co-NTA-MNPs, the enzyme loading is 
slightly higher probably due to the higher affinity between Co and His-tag. In addition, 
Co-NTA-MNPs could efficiently immobilize the His-CysM and remarkably recover the 
activity of the enzyme (89%). These results showed, along with the Ni-NTA-MNPs, 
which has been deeply studied in this thesis, Co-NTA-MNPs are also proven to be 
excellent nanocarriers in the simultaneous purification and immobilization of His-
CysM. The obtained nanobiocatalyst was used for synthesis of the unnatural amino 
acids and its performance was compared to the His-CysM-Ni-MNPs. 
5.3.3 Characterization of the MNPs and nanobiocatalysts 
The obtained magnetic nanobiocatalysts, His-CysM-Ni-MNPs and His-CysM-Co-
MNPs, were further characterized by TEM, SEM, EDX and VSM.  
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5.3.3.1 EDX 
The attachment of the nickel and cobalt metals on the Ni-NTA-MNPs was verified by 
recording EDX spectra of the Ni-NTA-MNPs and Co-NTA-MNPs, respectively. The 
EDX spectra are given in Figure ‎5.2. The spectrum in Figure ‎5.2.a shows characteristic 
peaks of Fe element, which belongs to iron oxide core at 0.71, 6.40 and 7.06 keV. The 
C and O characteristic peaks were also observed at 0.27 and 0.52 keV, respectively. In 
the spectrum of Co-NTA-MNPs in Figure ‎5.2.b, the repressive peaks of Co element 
were appeared at 0.78 and 6.93 keV, whereas these peak were absent in NTA-MNPs 
spectrum, indicating the successful attachment of cobalt metal on the NTA functions of 
the MNPs. The Co content of these MNPs was about 0.65 wt%. From the spectrum of 
Ni-NTA-MNPs in Figure ‎5.2.c, the characteristic peaks of the Ni element are exhibited 
at 0.84, 7.48 and 8.26 keV but these peaks did not appear in the NTA-MNPs spectrum, 
suggesting the successful attachment of the nickel metal on the NTA-MNPs. The Ni 
element content of the Ni-NTA-MNPs was 0.92 wt%. 
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Figure ‎5.2. EDX spectra: a) NTA-MNPs. b) Co-NTA-MNPs. c) Ni-NTA-MNPs. 
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5.3.3.2 VSM 
Both His-CysM-Ni-MNPs and His-CysM-Co-MNPs were characterized by VSM to 
study their magnetic properties. 
 
Figure ‎5.3. VSM curves of the Ni-NTA-MNPs (), His-CysM-Co-MNPs (), and His-CysM-
Ni-MNPs ().  
In Figure ‎5.3, the coercivity was zero for Ni-NTA-MNPs, His-CysM-Co-MNPs and 
His-CysM-Ni-MNPs, which is a strong evidence of superparamagnetic feature of these 
MNPs and nanobiocatalysts. The saturated magnetization values of Ni-NTA-MNPs, 
His-CysM-Ni-MNPs and His-CysM-Co-MNPs were obtained as 0.93, 0.79, and 0.87 
emu/g, respectively.  
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5.3.3.3 FESEM and TEM characterization of the nanobiocatalyst His-CysM-Co-
MNPs  
The size and morphology of the His-CysM-Co-MNPs were analyzed by FESEM and 
TEM images. From Figure ‎5.4.b, the nanobiocatalyst displayed a core-shell structure 
and spherical shape with a size of 80 nm, which is consistent with the size obtained for 
the His-CysM-Ni-MNPs (see Chapter 4). The narrow size distribution of the 
nanobiocatalyst His-CysM-Co-MNPs can be clearly seen from the FESEM image in 
Figure ‎5.4.a. 
 
Figure ‎5.4. FESEM (a) and TEM (b) images of the His-CysM-Co-MNPs. 
 
5.3.4 Syntheis of S-arylcysteines with nanobiocatalysts His-CysM-Co-MNPs 
and His-CysM-Ni-MNPs from OAS and arythiols 
The nanobiocatalysts His-CysM-Ni-MNPs (1.8 g enz./L) and His-CysM-Co-MNPs (2.0 
g enz./L) and their catalytic activity was compared to the corresponding 
biotransformations with the free enzyme. 
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Table ‎5.3. Synthesis of S-arylcysteines 2, 4, 8, 12, 14, and 16 by biotransformation of OAS and 
arylthiols 1, 3, 7, 11, 13, and 15 with His-CysM-Co-MNPs and His-CysM-Ni-MNPs. 
Entry Substrate 
a 
Nanobiocatalyst Product Yield (%) 
b 
1 1 His-CysM-Co-MNPs 2 96 
2 3 His-CysM-Co-MNPs 4 74 
3 7 His-CysM-Co-MNPs 8 60 
4 11 His-CysM-Co-MNPs 12 25 
5 13 His-CysM-Co-MNPs 14 71 
6 15 His-CysM-Co-MNPs 16 90 
7 1 His-CysM-Ni-MNPs 2 95 
8 3 His-CysM-Ni-MNPs 4 76 
9 7 His-CysM-Ni-MNPs 8 60 
10 11 His-CysM-Ni-MNPs 12 24 
11 13 His-CysM-Ni-MNPs 14 70 
12 15 His-CysM-Ni-MNPs 16 89 
a) The reactions were performed in 1 mL of 300 mM KP buffer (pH 7.0 with 1.1 mM PLP) 
with 2.0 and 1.8 g enz./L immobilized His-CysM for His-CysM-Co-MNPs and His-CysM-Ni-
MNPs, respectively. 100 mM OAS and 1.2:1 molar ratio of the arylthiol to OAS were 
incubated in a tube tumbler at 30 rpm and 35 °C for 1 h. b) Determined by HPLC analysis 
considering the OAS deduction during the biotransformation.  
The product yield (%) of the corresponding S-arylcysteines that obtained from 
substrates 1, 3, 7, 11, 13, and 15 are presented in Table ‎5.3. There was no significant 
difference in the product yield obtained from His-CysM-Ni-MNPs and His-CysM-Co-
MNPs. The excellent activity retention of His-CysM on the both Ni-NTA-MNPs and 
Co-NTA-MNPs assisted to replicate the corresponding free enzyme system results 
(Table ‎5.1, entries 1–8) with the nanobiocatalysts. For instance, for the substrates 1, 3, 
7, 11, 13 and 15 (Table ‎5.3, entries 1–6), the nanobiocatalyst His-CysM-Co-MNPs 
afforded 96%, 74%, 60%, 25%, 71%, and 90% yield of products 2, 4, 8, 12, 14, and 16, 
respectively. These results are consistent with the corresponding products yield 
obtained with free His-CysM, providing 92–100% retention of activity of free enzyme 
in the corresponding biotransformation. In addition, same as the free His-CysM, there 
was no activity observed towards substrates 5 and 9 for both nanobiocatalysts. 
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The representative HPLC chromatograms of the products 2, 4, 12, 14 and 16 are 









Figure ‎5.5. The representative HPLC chromatograms of the products 2, 4, 12, 14 and 16. 
5.3.5 Characterization of the synthesized unnatural amino acids by 1H NMR and 
13
C NMR 





C NMR. These spectra (Figure ‎5.6) give a clear evidence of the formation of the 
products with the desired chemical structure. In all 
1
H NMR spectra, protons on the 
benzene ring gave peaks in the range of 6.9 to 7.8 ppm and protons of the cysteine 
group appeared in the range of 2.8 to 3.8 ppm. The simultaneous appearance of protons 




successful and provided S-arylcysteines as expected. For instance, in the 
1
H NMR 
spectrum of product 2 (Figure ‎5.6.a), three protons of the cysteine function appeared at 
3.17, 3.25, and 3.70 ppm and the peaks at 6.96, 7.22, 7.47 ppm belongs to four protons 
of the benzene ring. 
The chemical structures were further confirmed by recording 
13
C NMR spectra. The 
carbons of the benzene ring gave peaks in the range of 119 to 143 ppm and carbon of 
the carboxylic acid function in the cysteine emerged at 172 ppm, whereas carbon of the 
amine gave peak at 53 ppm and the carbon that bonded to sulfur appeared at 34-36 
ppm. 
The detailed analysis of each spectrum elaborating all peaks and their corresponding 
















Figure ‎5.6. 1H NMR and 13C NMR characterization of the synthesized S-arylcysteines from 
substrates 1, 3, 11, 13 and 15. a) 1H NMR of 2. b) 13C NMR of 2. c) 1H NMR of 4. d) 13C NMR 




5.3.6 Recycling and reuse of nanobiocatalysts His-CysM-Ni-MNPs and His-CysM-
Co-MNPs for the synthesis of 16  
The use of the immobilized enzymes can enhance the total productivity (per amount of 
biocatalyst) and reduce the biocatalyst cost when it can be efficiently recycled and 
reused. Therefore, the recyclability of the both His-CysM-Ni-MNPs (1.8 g His-
CysM/L) and His-CysM-Co-MNPs (2.0 g His-CysM/L) were examined in 
biotransformation of the 15 to 16 using 1mL KP buffer (300mM, pH 7.0, and 1.1 mM 
PLP) 100 mM initial OAS and 120 mM 15 at 35 °C and 30 rpm of shaking with a tube 
tumbler for 40 min. After each cycle, the nanobiocatalysts were separated with a 
magnet (Figure ‎5.7) and washed with KP buffer and reused at the same reaction 
conditions. 
 
Figure ‎5.7. Separation of the His-CysM-Co-MNPs from reaction mixture in biotransformation 
of 15 to 16. a) Reaction mixture containing His-CysM-Co-MNPs. b) Separation of His-CysM-
Co-MNPs from reaction mixture with magnet (for 60 s). 
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In Figure ‎5.7.a, His-CysM-Co-MNPs are dispersed well in the reaction mixture while 
Figure ‎5.7.b displays the separation of the His-CysM-Co-MNPs. Although the product 
16 has a very low solubility in water and precipitates, the separation of the 
nanobiocatalysts by aid of their magnetic properties enables to recover them from the 
reaction mixture containing precipitated 16. Without the magnetic feature, it might be 
very difficult to separate a heterogeneous catalyst mixed with a precipitated product. 
Centrifugation and filtration will result with a catalyst-product mixture and increasing 
the solubility of the product by lowering pH probably can inactivate the enzyme (pH 
preference of 6.9–7.4).  
 
Figure ‎5.8. Recycling and reuse of nanobiocatalysts His-CysM-Co-MNPs and His-CysM-Ni-
MNPs at 16 mg nanobiocatalyst loading (containing 2 g immobilized enz./L) in the 
biotransformation of OAS (100 mM) and 15 (120 mM) to 16 at 35 °C for 40 min. 
The recycling results are given in Figure ‎5.8. It was observed that His-CysM-Co-MNPs 
had better recyclability compared to the His-CysM-Ni-MNPs, retaining 95% of its 
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productivity in fifth cycle, which is higher than 80% productivity retention of His-
CysM-Ni-MNPs in fifth cycle. 
His-CysM enzyme could partially leak out from His-CysM-Ni-MNPs in the presence of 
OAS, as discussed in details in Chapter 4. However, the product of this 
biotransformation (16) has no interaction with affinity bonding between His-tag and 
metal, thus the productivity retention is higher than PAA production. Also, it is clear 
that His-CysM-Co-MNPs have more stable affinity bonding with His-CysM. 
5.4 Conclusion 
In conclusion, a group of S-arylcysteines, which are useful pharmaceutical 
intermediates, successfully synthesized by biotransformation of OAS and various 
arylthiols with His-tagged OASS CysM. This enzyme was found to have a broad 
substrate acceptance towards arythiols. The substrates 1, 3, 7, 13, and 15 gave the 
corresponding products with 96, 79, 62, 73, and 88% yield, respectively, using 2.0 g 
enz./L. The CysM enzyme showed less activity towards substrate 11, and no activity 
towards 5 and 9. These results showed that CysM has high activity towards benzyl 
mercaptan and amide substituted thiophenols. The activity changed by changing the 
substitutes, suggesting the chemoselectivity of CysM towards substituted thiophenols. 
This chemoselectivity was clear in 4- substituted arylthiols where it showed no activity 
towards hydroxyl substituted thiophenol but catalyzed carboxylic and acetamido 
substitutes. The chemoselectivity was also valid for 2- substituted arylthiols giving no 
activity for hydroxyl but very high activity towards amid substituted thiophenol. CysM 
showed regioselectivity towards hydroxyl substituted thiophenols, affording 62% yield 
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for biotransformation of substrate 7 (3-hydroxylthiophenol) to 8 while gave no activity 
for 2- and 4-hydroxythiophenol. Moreover, the successful production of this group of 
S-arylcysteines evidenced by 
1
H NMR and 
13
C NMR analysis. 
The nanobiocatalysts, His-CysM-Ni-MNPs and His-CysM-Co-MNPs, were prepared 
with simultaneous purification and immobilization of the His-CysM from its CFE. 
These nanobiocatalysts exhibited excellent enzyme activity retention and they were 
able to almost replicate the activity of the free enzyme system, possessing 92–100% of 
the activity of the free enzyme in the corresponding biotransformation. Moreover, these 
nanobiocatalysts proved to be recyclable. In production of 16 from 15 with 100 mM 
initial OAS, nanobiocatalysts simply separated and recovered from the reaction mixture 
by a magnet. Recycling and reuse of His-CysM-Co-MNPs and His-CysM-Ni-MNPs 
exhibited excellent productivity retention of 95% and 80% in the fifth cycle, 
respectively. These biotransformations provide a simple and efficient synthesis of a 
group of S-arylcysteines that are useful or could be potentially useful pharmaceutical 
intermediates. The use of immobilized enzymes with high activity and excellent 
recyclability offers a more productive process for these biotransformations. 
  
131 
Chapter 6 Enzymatic Ring-Opening 
Polymerization of Cyclic Monomers Using 
Immobilized His-tagged TLL on Magnetic 
Nanoparticles 
6.1 Introduction 
The synthesis of polyesters from ring-opening polymerization has attracted much 
interest because of the significant importance of these polymers as 
biomaterials.
[165,199,200]
 A clean process is highly preferred for this application to obtain 
high-purity and metal-free products. The utilization of heavy metals and organometallic 
catalysts for ring-opening polymerization (ROP) of lactones
[164,201,202]
 show low activity 
towards lactones with large ring size 
[203]
 and more importantly pollute the final product 
with toxic metal remnant; thus, these catalysts are less favored.
[165]
 On the other hand, 
enzymatic polymerization is charming due to the several advantages such as non-
toxicity, mild reaction conditions, and high regio-, chemo- or stereoselectivity.
[162,204-208]
 




Lipases are the most frequently reported enzymes for the ROP of lactones.
[170,213,214]
 
Those lipases that are stable and active in organic media and at relatively high 
temperatures (50–80 °C) are the candidates for enzymatic ROP of lactones.[215-217] 
Thermomyces lanuginosus lipase (TLL) is a thermophilic enzyme and stable at 50–
80 °C.
[173,218]
 It has found several applications
[133]




 enantioselective hydrolysis and resolution of racemic mixtures,
[220]
 
and biodiesel production. Here, for the first time, we aim to explore the activity of TLL 
in the synthesis of polyesters with broad biomedical applications
[167,221]
 by ROP of 
cyclic monomers. Because of the stability of the immobilized enzyme, the use of 
immobilized His-TLL is mainly studied (Scheme ‎6.1).  
Since MNPs offer high dispersity, less mass transfer limitations and easy separation 
from reaction mixture,
[21,68]
 immobilizing enzymes on the MNPs have been performed 
and successfully used for several applications.
[24]
 The immobilized enzyme on the 
MNPs may enhance the polymerization rate compared to the conventionally used 
immobilized enzymes on the mesoporous microbeads due to the enhanced mass transfer.  
 
Scheme ‎6.1. Investigating the activity of His-TLL-MNPs for ring-opening polymerization of 
the various cyclic monomers. 
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However, to the best of our knowledge, there is no report on using immobilized 
enzymes on the MNPs for enzymatic polymerization. To prepare the immobilized His-
TLL, a simple and efficient method for simultaneous purification and immobilization of 
extracellular His-TLL using Ni-NTA-MNPs was demonstrated in Chapter 3. This study 
may pave the way to further investigate the potential applications of the TLL as enzyme 
and MNPs as nanocarriers for the enzymatic polymerization. 
6.2 Experimental section 
6.2.1 Materials 
δ-valerolactone (VL) (98%) was purchased from TCI. D-lactide (99%) was a gift from 
Purac
®
. ε-caprolactone (CL) (97%), ω-pentadecalactone (PDL) (≥9 %), β-
butyrolactone (β-BL) (98%), δ-hexalactone (δ-HL) (≥9 %), n-dodecane (≥9 %) were 
purchased from Sigma. Toluene (anhydrous, ≥99.8%) obtained from Acros. 
Tetrahydrofuran, methanol, chloroform and dichloromethane purchased from Sigma in 
HPLC grade.  
6.2.2 Gas chromatography (GC) 
The conversion (%) of CL and VL during the ring-opening polymerization of these 
lactones was determined by injection of 1 μL of sample in GC chromatograph (Agilent 
7890A) equipped with HP-5, Agilent column (30 m × 0.32 mm × 0.25 mm). The 
column kept at 80 °C for 1 min, then heated to 180 °C in a rate of 20 °C min
-1
 and 




 to reach 230 °C and kept for 14 min. 
Retention times were 4.83 min for CL and 3.82 min for VL. 
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6.2.3 Gel Permeation Chromatography (GPC) 
The molecular weights and polydispersity index (PDI) of the polymers were analyzed 
by GPC using a PLgel 10 μm Mixed-B, Agilent. Samples contained about 0.2% (w/v) 
of polymer and injected in 100 µL volume and analyzed using THF as eluent (1.0 
mL/min) at 30 °C. The calibration curves were generated with polystyrene standards. 
6.2.4 Fourier transform infrared spectroscopy (FTIR) 
The FTIR spectra were recorded employing KBr pellet with a wavenumber range of 
400 – 4000 cm-1 by Bio-Rad FTS 135 spectrophotometer. 
6.2.5 Nuclear magnetic resonance (NMR) 
1
H NMR spectra were recorded on a Bruker (DRX500) at 500 MHz and chemical shifts 
were on the basis of the reference peak of tetramethylsilane at 0.00 ppm.  
6.2.6 Preparation of nanobiocatalyst His-TLL-MNPs 
The synthesis of Ni-NTA-MNPs and preparation of the His-TLL enzyme as well as the 
nanobiocatalyst, His-TLL-MNPs, was according to the procedures described in Chapter 
3. The His-TLL loading on the Ni-NTA-MNPs was 62 mg/g of MNPs. 
6.2.7 Bulk ring-opening polymerization of ε-caprolactone 
0.7 g CL was dried using molecular sieves (3 Å) at 45 °C under argon and stirred 
overnight. 40 mg lyophilized His-TLL-MNPs weighed and transferred into 10 mL 
schlenck tube with a magnetic stirring bar inside and dried in vacuum oven at 45 °C for 
12 h. After that, the schlenck tube containing nanobiocatalyst covered by septum rubber 
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and 420 mg dried CL (9.5 wt% of catalyst carrier loading) was added into the tube 
under argon using syringe (was flushed with argon prior to use) at 70 °C. The 
polymerization was stopped after 12 h by addition of 1.5 mL chloroform and the 
nanobiocatalyst was recovered by magnet. The product was precipitated by addition of 
10:1 (v/v) methanol to chloroform at 4 °C and filtered using a filter paper and dried in 
vacuum oven at room temperature for 24 h and 62% yield was obtained on the basis of 
ε-caprolactone. 
6.2.8 Ring-opening polymerization of lactones in toluene 
40 mg lyophilized His-TLL-MNPs (or Novozym 435) was dried as described above 
before polymerization. 0.7 g monomer (VL, CL, PDL, β-BL δ-HL or D-lactide) was 
added into a schlenck tube (with 17 mg n-dodecane as internal standard of GC for 
determining conversion of VL and CL) and 3   molecular sieves were mixed at 45 °C 
under argon overnight to dry. 420 mg monomer (containing n-dodecane if used) and 
0.84 mL of anhydrous toluene (2:1 v/w ratio of solvent to monomer) were added into 
the tube containing nanobiocatalyst under argon to start polymerization at 70 °C (60 °C 
for D-lactide). For the monomer conversion determination of VL and CL, aliquots were 
withdrawn at 3, 6, 12, 28 min, and 3, 11 and 24 h. After separating of the 
nanobiocatalyst by magnet, a portion of the samples were diluted in dichloromethane 
(50X) for GC and another portion was used for GPC after diluting in THF (0.2 wt%). 
The polymerization was stopped by addition of 1.5 mL chloroform and the 
nanobiocatalyst was separated by magnet. For the ROP of PDL, it was terminated after 
2.5 h by addition of 1.5 mL chloroform and the nanobiocatalyst was separated by 
magnet at 50 °C. The solvents were evaporated from the mixture using rotary 
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evaporator (70 mHg, 60 °C) and the raw products were dissolved in 1 mL chloroform 
and precipitated in methanol (10:1 v/v) at 4 °C, filtered and dried in vacuum oven at 
room temperature. Typical isolated polymer yields of 50–60% were obtained from ROP 
of VL, CL and PDL.  
PVL (50% isolated yield), 
1
H NMR (DMSO-d6, 500 MHz): δ 4.00 (2H, t, J=5.4 Hz), 
2.32 (2H, t, J=6.8 Hz), 1.62–1.50 (4H, m). 
PCL (62% isolated yield), 
1
H NMR (DMSO-d6, 500 MHz): δ 3.98 (2H, t, J=6.3 Hz), 
2.28 (2H, t, J=7.2 Hz), 1.62–1.45 (4H, m), 1.36–1.21 (2H, m). 
PPDL (52% isolated yield),
 1
H NMR (Chloroform-d, 500 MHz): δ 4.05 (2H, t, J=6.8 
Hz), 3.64 (CH2OH, t, J=6.6 Hz), 2.28 (2H, t, J=7.6 Hz), 1.60 (4H, dd, J=14.8, 7.7 Hz), 
1.42–1.10 (20H, m). 
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6.3 Results and discussion  
6.3.1 Bulk ring-opening polymerization of ε-caprolactone catalyzed by His-TLL-
MNPs 
The nanobiocatalyst His-TLL-MNPs was used for the ROP of CL to prepare poly(ε-
caprolactone) (PCL) via bulk polymerization at 70 °C (Table ‎6.1, entry 2). The 
obtained PCL gave Mn = 10000 g/mol (Mw = 21000 g/mol). The GPC chromatogram of 
this polymerization is presented in Figure ‎6.1. 
 
Figure ‎6.1. GPC chromatogram of PCL obtained from ROP of ε-caprolactone catalyzed by 
His-TLL-MNPs.  
6.3.2 ROP of lactones in toluene with nanobiocatalyst His-TLL-MNPs 
To further study the activity of His-TLL-MNPs, the ROP of lactones (6-, 7- and 16-
membered) were conducted in the organic media (toluene). The ROP of unsubstituted 
lactones were conducted in toluene as organic media with His-TLL-MNPs at 70 °C 
(Table ‎6.1, entries 1–3 and 5). For the CL as monomer, the PCL with Mn = 10000 g/mol 
(Mw = 21000 g/mol) was obtained.  
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1 VL 6 2 11 11000 4300 2.6 43 50 
2 CL 7 2 12 21000 10000 2.1 88 61 
3 CL 7 - 11 22400 5600 4.0 49 62 
4 CLc 7 2 11 24500 10500 2.3 92 58 
5 PDL 16 2 2.5 nd d 11200e nd 47 52 
6 β-BL 4 2 24 1100 900 1.2 9 15 
7 δ-HL 6 2 24 900 800 1.1 7 14 
8 D-lactide 6 2 24 1200 1100 1.3 8 20 
All the lactones were catalyzed by His-TLL-MNPs (9.5 wt% nanobiocatalyst loading) at 70 °C 
under argon. The polymerization of the D-lactide was performed at 60 °C. a) Polydispersity 
index (PDI) of polymers obtained from GPC measurements on the basis of PDI = Mw/Mn. b) 
Degree of polymerization (DP) was calculated from Mn and the molecular weight of repeating 
units. c) Novozym 435 was used as catalyst (9.5 wt% loading) in the same reaction conditions 
described above. d) The GPC was not performed since the obtained polymer is not soluble in 
THF. e) Calculated by 1H NMR considering ratio of peak area at 4.05 to 3.64 ppm (determined 
as 45.4). 
Compared with the bulk, the PDI was narrower with an increased Mn. As a result, DP 
was increased from 49 in the bulk polymerization to 88 in the toluene as solvent. To 
further evaluate the catalytic performance of His-TLL-MNPs in ROP of lactones, the 
ROP of CL with Novozym 435 was also conducted at the same reaction conditions of 
using toluene as solvent (Table ‎6.1, entry 4). The polymer obtained showed a Mn = 
10500 and PDI = 2.3, suggesting that His-TLL-MNPs have almost the same activity as 
Novozym 435 towards CL. However, at the same catalyst loading (9.5 wt % monomer), 
considering enzyme loading on the carriers, His-TLL-MNPs (contained 6 wt% enzyme 
on the catalyst) was used at 0.6% w/w TLL to monomer and Novozym 435 (contained 
10 wt% enzyme on the catalyst) was loaded at 1% w/w CALB to monomer. Therefore, 
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His-TLL-MNPs gave a higher specific enzyme activity compared to the immobilized 
CALB (Novozym 435). 
The polymerization of VL was also successful and Mn = 4300 g/mol with PDI = 2.6 
was achieved. The Mn of poly(δ-valerolactone) (PVL) was lower than the PCL at the 
same reaction conditions and time. The polymerization of PDL by His-TLL-MNPs was 
also performed and it was very fast compared to the other two lactones (with smaller 
ring size) and the reaction mixture was very viscous at 2.5 h and was stopped to further 
analyze the product after isolation. The obtained poly(ω-pentadecalactone) (PPDL) had 
Mn = 11200 g/mol. Considering the reaction time and obtained Mn values, it can 
observed that the activity of the His-TLL-MNPs increased by the increasing of the ring 
size. This phenomenon has been reported for other lipases such as CALB (Novozym 
435).
[209,221]




The polymerization of methyl substituted lactones (β-BL and δ-HL), however, gave 
oligomers with DP = 7–9 (Table ‎6.1, entries 6 and 7). The GPC results for these 
monomers (not presented) showed that oligomers were formed in the early stage of 
polymerization but did not progress afterwards. Also, the monomer conversion was not 
quantitative after 24 h. These observations suggest that probably enzyme was 
deactivated in the presence of β-BL or δ-HL in the early stage of the reaction. This drop 
in the activity is also reported for some other lipases for this type of monomers.
[209,216]
 
The early efforts for the enzymatic ROP of β-BL only gave oligomers (DP = 3–12) 
when porcine pancreatic lipase or lipase from Pseudomonas cepacia were used.
[223]
 




 The ROP of D-lactide also afforded oligomers of poly(D-lactic acid) with 
DP = 8 (Table ‎6.1, entry 8), which indicates His-TLL-MNPs shows low activity towards 
ROP of D-lactide and it might be possible to enhance using different solvents (i.e. ionic 
liquids) and reaction conditions to enhance the polymer molecular weight. 
6.3.3 Monomer conversion and reaction rates for the ROP of δ-valerolactone and 
ε-caprolactone catalyzed by His-TLL-MNPs 
To study the catalytic performance of the His-TLL-MNPs, the conversion of the CL 
and VL monomers during the polymerization was determined. As it can be seen in 
Figure ‎6.2, the conversion of both monomers, especially CL, is extremely high at the 
beginning. It takes only 6 min to reach 47% and 27% monomer conversion of the CL 
and VL, respectively.  
 
Figure ‎6.2. Monomer conversion respect to time for CL () and VL () in the ring-opening 
polymerization catalyzed by His-TLL-MNPs at 2:1 (v/w) ratio of toluene to monomer and 
70 °C. 
This high activity in the initial is probably due to the enhanced the mass transfer when 
nanobiocatalyst is used since the immobilized enzymes on the surface of MNPs are 
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accessible for the monomers. This is also a strong evidence that affinity immobilization 
of the His-TLL does not disturb enzyme activity and provides highly active 
immobilized enzymes. 
 
Figure ‎6.3. Semilogarithmic plots of ring-opening polymerization of CL () and VL () 
respect to time, catalyzed by His-TLL-MNPs in toluene (ratio of toluene to monomer 2:1 (v/w)) 
at 70 °C.  
Kinetics of chain growth for the ROP of CL and VL catalyzed by His-TLL-MNPs was 
studied from the linear regression analysis of semilogarithmic ln(M0/Mt) versus 
reaction time plots (Figure ‎6.3) for these monomers with high accuracy (R2 ≥‎ 0.9 ).‎
From this analysis, it was observed that chain growth follows first-order kinetics with 
respect to time and chain termination did not occur in these polymerizations.  
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Figure ‎6.4. The Mn of the polymers with respect to monomer conversion during the 
ring-opening polymerization of the CL () and VL () catalyzed by His-TLL-MNPs 
in toluene at 70 °C. 
Also, from Mn versus conversion plots in Figure ‎6.4, the linear behavior in the increase 
of Mn up to 90% of monomer conversion can be seen, indicating absence of chain 
transfer and occurrence of propagation at the chain ends for chain growth. These results 
shows that TLL follows the same mechanism as reported for other lipases (CALB, 
Porcine pancreatic lipase and Humicola insolens cutinase) for the ROP of CL. 
Figure ‎6.4 indicate that molecular weight of the polymers were gradually increased in 
the earlier stage of the polymerization when the monomer conversion was relatively 
low and larger polymer molecules were formed at higher conversions. 
In the His-TLL-MNPs catalyzed ROP, the initial rate constant (ki) for the CL is almost 
double that of VL, reaching to 6.34 and 3.08 h
-1
, respectively. The TON (kcat) that was 
determined by taking into account ki was also high for both monomers and reached 
4367 and 2093 min
-1
 for CL and VL, respectively. These data are listed in Table ‎6.2. 
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Table ‎6.2. Evaluation of initial rate constants and turnover numbers for ring-opening 















VL 3.08 2.0 49.1 2093 
CL 6.34 2.0 48.4 4367 
a) Initial rate constant (ki) was calculated from the linear fit on the initial 6 min of the ln 
(M0/Mt) versus time (R
2
 > 97%). b) The molar concentration of the utilized 
immobilized enzyme was obtained on the basis of nanobiocatalyst loading (9.5 wt% of 
monomer), enzyme loading on the MNPs of 62 mg/g MNPs (~5.8 wt% of 
nanobiocatalyst) and His-TLL molecular weight of 35 kDa. c) Turnover number (TON) 
was the mole of converted lactone to polymer per mole of His-TLL per min and 
calculated as TON = [ki (h
-1
) × lactone (mol/L)]/[60 × His-TLL (mol/L)]. 
These values emphasize the high catalytic activity of the His-TLL-MNPs for ROP of 
lactones. For instance, the immobilized Humicola insolens Cutinase have a reported 
TON of 770 min
-1
 in the ROP of CL at 70 °C,
[216]
 which is much lower than 4367 
obtained for His-TLL-MNPs. The TON for the Novozym 435 (CALB) catalyzed ROP 
of CL and VL at 60 °C is reported as 4374 and 2112 min
-1
, which is only slightly 
higher than the His-TLL-MNPs.
[221]
 It is worth noting that to determine TON of the  
Novozym 435 catalyzed ROP, the protein content of the catalyst was assumed 2 wt%, 
which is reported to be higher (10 wt%)
[58,225]
 and this resulted to calculate high TON 
values for Novozym 435 in their polymerizations.  
6.3.4 Characterization of synthesized poly lactones 
The isolated polymers from His-TLL-MNPs catalyzed ROP of VL, CL and PDL were 
further characterized to confirm their successful synthesis.  
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6.3.4.1 Fourier transform infrared spectroscopy (FTIR) characterization of the 
synthesized PVL, PCL and PPDL by ROP of lactones using His-TLL-MNPs 
FTIR spectra of polymers were recorded and the corresponding spectra of the PVL, 
PCL and PPDL are plotted in Figure ‎6.5. The characteristic peak of carbonyl group 
(─C═O)‎ appeared‎ at‎ 1725‎ cm-1 for the polymers that can arise from ester bond, 
whereas two peaks at about 2850–2870 cm-1 and 2900–2958 cm-1 can be attributed to 
methylene groups (─CH2) in the polymer backbone. The‎ C─O‎ stretch‎ characteristic‎




Figure ‎6.5. FTIR spectra of a) PPDL, b) PVL (2), and c) PCL synthesized by His-TLL-MNPs 
catalyzed ROP of the corresponding MNPs. 
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6.3.4.2 Nuclear magnetic resonance (NMR) characterization of the PVL, PCL and 
PPDL synthesized ROP of lactones by His-TLL-MNPs 
The 
1
H NMR spectra of the PVL, PCL, and PPDL were recorded using isolated 
polymers and presented in Figure ‎6.6. 
As it can be seen in Figure ‎6.6, the 1H NMR spectra gave a characteristic peak of CH2O 
at 4.00, 3.98, and 4.05 ppm for PVL, PCL and PPDL polymers, respectively. These 
peaks would reportedly appear in a range of 4.15–4.20 ppm for the unreacted 
lactones,
[226]
 indicating the successful synthesis of these polyesters by His-TLL-MNPs 





Figure ‎6.6. NMR spectra of a) PVL, b) PCL, and c) PPDL obtained from ROP of VL, CL, and 
PDL catalyzed by His-TLL-MNPs.  
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6.4 Conclusion 
In summary, the activity of the immobilized His-TLL was investigated for the 
enzymatic ROP of various lactones and D-lactide. Magnetic nanobiocatalyst His-TLL-
MNPs were prepared using Ni-NTA-MNPs for simultaneous purification and 
immobilization of extracellular His-TLL and used as an active nanobiocatalyst for ROP 
of cyclic monomers. His-TLL-MNPs showed high activity for the ROP of CL in bulk 
as well as in toluene as organic media, affording Mn of 5600 g/mol (PDI = 4.0) and 
10000 g/mol (PDI = 2.1), respectively. The further studies revealed that it can also 
catalyze ROP of VL (Mn = 4300 g/mol) and PDL (Mn = 11200 g/mol). The ROP of 
both PVL and PCL occurred relatively fast and completed at 11 h, while the ROP of 
PDL by His-TLL-MNPs was even faster and terminated in 2.5 h. These results showed 
that the activity of TLL increased by increase in the ring size of unsubstituted lactones. 
Moreover, Novozym 435 at loading of 1% w/w CALB to monomer gave PCL with Mn 
= 10500 g/mol in toluene; whereas, His-TLL-MNPs catalyzed the same ROP with only 
0.6% w/w TLL to monomer, suggesting that TLL has a higher specific activity in ROP 
of CL.  
Further studies on the conversion of monomers (VL and CL) revealed first-order 
kinetics of chain growth (respect to monomer conversion) and without chain 
termination. Also, a linear relation of Mn and monomer conversion indicated chain 
growth happened from the chain ends. The TON of His-TLL-MNPs was 2093 and 4367 
min
-1
 for VL and CL as monomer, respectively, representing its great catalytic 
performance for the ROP of unsubstituted lactones. The ROP of methyl substituted 
lactones (β-BL and δ-HL) and D-lactide gave oligomers (DP = 7–9). These results 
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clearly exhibited the high activity of TLL for the ROP of various cyclic monomers for 
the first time. Moreover, the application of magnetic nanobiocatalysts was successfully 
demonstrated for the first time with excellent catalytic performance and high reaction 
rates. This study shows the great potential of the functionalized MNPs for the 
immobilization of the enzymes to be used in enzymatic polymerization reactions. For 
this purpose, affinity immobilization of His-tagged enzyme on the MNPs as 
demonstrated in this work could be a simple and appropriate immobilization approach 
for preparation of active and stable nanobiocatalysts. 
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Chapter 7 Conclusion and Recommendations  
7.1 Conclusions 
Enzyme immobilization is a useful tool to stabilize the enzyme and reduce the 
biocatalyst cost through recycling and MNPs are great carriers for enzyme 
immobilization. The simple and efficient preparation of active and recyclable magnetic 
nanobiocatalysts via simultaneous purification and immobilization of His-tagged 
enzymes with the functionalized MNPs and exploring the application of these 
nanobiocatalysts for production of biodiesel, pharmaceutical intermediates and 
polyesters were the main objectives of this thesis. Several enzymes were immobilized 
and the obtained magnetic nanobiocatalysts were characterized and used in various 
clean and green biotransformations to study their catalytic performance, activity and 
recyclability.  
In more details, first, the magnetic nanoparticles with an iron oxide core and a 
poly(glycidyl methacrylate) shell were synthesized and the long-armed Ni-NTA surface 
function was introduced to achieve simultaneous purification and immobilization of 
His-tagged enzyme and retain the enzyme activity after immobilization. The P. pastoris 
(h-TLL)-produced extracellular His-TLL was efficiently immobilized on the Ni-NTA-
MNPs directly from the cell culture supernatant. The small amount of nanobiocatalyst 
afforded 94% FAME yield from waste grease and methanol and the stability of the 
enzyme was excellent, retaining 97% productivity after seven cycles. The possibility of 
regeneration of the Ni-NTA-MNPs from the recycled nanobiocatalyst was also 
successfully demonstrated, which can further decrease the synthesis cost of the MNPs. 
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Moreover, the generality of the proposed approach was validated by immobilizing 
extracellular His-CALB for the esterification of waste grease, giving 98% FFA removal 
and excellent recyclability. 
Second, the simultaneous purification and immobilization of His-tagged OASS CysK 
and CysM was carried out on the Ni-NTA-MNPs from the corresponding CFE. High 
enzyme loadings of 190 mg His-CysM and 150 mg CysK per gram MNPs were 
achieved by tuning the protein concentration in the CFE. These nanobiocatalysts were 
used to synthesize β-pyrazol-1-yl-alanine, affording high product yield with negligible 
difference in their performance compare to the free enzyme or CFE systems. In 
comparison, CysK could tolerate higher substrate concentrations (90 mM OAS) and 
showed higher specific activity towards pyrazole as nucleophile. The recyclability of 
both enzymes was carried out and possible causes of enzyme leakage were also studied. 
After a simple pretreatment of immobilized His-CysK with PAA, the productivity 
retention was improved from 57% (for non-treated His-CysK-MNPs) to 77% in the 
tenth cycle by using same immobilized His-CysK concentration (2.4 g/L). The 
pretreated His-CysK-MNPs were recycled for twenty batches without a significant drop 
in the productivity. 
Third, a group of unnatural amino acids (S-arylcysteines) were synthesized at high 
OAS concentration (100 mM) by free and immobilized His-CysM on the Co-NTA-
MNPs and Ni-NTA-MNPs. These biotransformations gave high yields (up to 96%) in a 
short biotransformation time. Regio- and chemoselectivity of CysM towards the 
substituted thiophenols were observed. CysM gave 62% yield for 3-
hydroxybenzenethiol as substrate but this enzyme could not accept 2- and 4-hydroxyl 
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substituted thiophenols, suggesting that it is regioselective towards hydroxyl substituted 
thiophenols. However, it converted 2-aminobenzenethiol and OAS to the corresponding 
S-arylcysteine in 96% yield, which is a strong evidence of chemoselectivity of CysM 
for the substituted thiophenols. The successful synthesis of the products was confirmed 
by recording their 
1
H NMR and 
13
C NMR spectra. In addition, the excellent activity of 
the immobilized His-CysM on the Ni-NTA-MNPs or Co-NTA-MNPs almost replicated 
the free enzyme activity for the corresponding biotransformations. Both 
nanobiocatalysts were recyclable and His-CysM-Co-MNPs gave a relatively more 
stable nanobiocatalyst, resulting higher productivity retention (95%) than His-CysM-
Ni-MNPs (80%) after five cycles.  
Fourth, His-TLL-MNPs were employed to catalyze ring-opening polymerization of 
cyclic monomers. The nanobiocatalyst was active in polymerization in bulk or toluene 
at 70 °C. The activity of His-TLL-MNPs towards unsubstituted lactones was high with 
an increase in the activity for the larger lactones, giving polyesters with Mn = 4300–
11200 g/mol. Moreover, the oligomers with degree of polymerization of 7 to 9 were 
obtained from ROP of substituted lactones and D-lactide. Moreover, the impact of using 
nanobiocatalyst for enzymatic ROP was clear with high initial monomer conversion 
rates and fast polymerization reactions (2.5–11 h). The TON of the His-TLL-MNPs 
was very high indicating its great potential for the ROP of cyclic monomers.  
Overall, this thesis has contributed in several aspects to fabricate active, stable, and 
recyclable nanobiocatalysts through a simple method for green and environmental 
benign biotransformations. In this thesis, the magnetic nanoparticles with a Ni-NTA or 
Co-NTA functions were introduced to the surface of MNPs via a long-armed spacer to 
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not only purify and immobilize His-tagged enzymes, which is widely reported in the 
litrature, but also retain the activity of the free enzyme after immobilization and use the 
obtained immobilized enzymes as active, stable, and recyclable magnetic 
nanobiocatalysts. Hence, the simplicity and efficiency of His-tagged affinity 
immobilization for preparation of the nanobiocatalysts was demonstrated by using 
synthesized MNPs. These MNPs can be applied directly for the simultaneous 
purification and immobilization of extracellular His-tagged enzymes from cell culture 
supernatant of the recombinant P. pastoris even at low protein concentrations, 
providing highly active nanobiocatalysts. This can be generally a simple and useful 
enzyme immobilization method to avoid both cell disruption and enzyme purification 
steps. 
The first time immobilization of the His-tagged OASS CysK and CysM from CFE gave 
high enzyme activity recovery after immobilization. The rapid biotransformations due 
to the high free enzyme activity retention after immobilization and less mass transfer 
limitations of these nanobiocatalysts helped to relief the isomerazation of OAS to NAS 
at the reaction pH and achieve high product yields in quick reactions. The recyclability 
of the developed nanobiocatalysts greatly enhanced the productivity of the enzymatic 
synthesis of β-pyrazol-1-yl-alanine compared to the previously reported whole-cell or 
free enzyme systems. 
Moreover, the chemo- and regioselectivity of the OASS CysM towards the substituted 
thiophenols was found in sulfhydrylation of these compounds with OAS to produce S-
arylcysteines. This can contribute to prepare highly valuable and potentially useful 
pharmaceutical intermediates with new chemical structures functions via a green 
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reaction route. In addition, the MNPs with Co-NTA functions proved to provide more 
stable immobilized His-CysM compared to the Ni-NTA-MNPs for the catalyst 
recycling. Also, an important application of the magnetic separation of the magnetic 
nanobiocatalysts for catalyst recycling was successfully demonstrated by recycling and 
reuse of His-CysM-Co-MNPs or His-CysM-Ni-MNPs in presence of less soluble 
products that can precipitate such as S-benzyl-L-cysteine. The magnetic separation 
facilitates the isolation of such products as well as the catalyst recovery compared to 
the catalyst separation via centrifugation or precipitation; thus, this approach could be 
useful for the similar reactions and processes. 
In addition, the application of the magnetic nanobiocatalyst for the enzymatic 
polymerization was successfully demonstrated for the first time. Furthermore, the first 
systematic study on the activity of the immobilized His-TLL for the ring-opening 
polymerization exhibited a great potential of this enzyme for the enzymatic 
polymerization of various cyclic monomers. 
In conclusion, we have successfully demonstrated a simple and efficient immobilization 
method employing His-tag affinity with metal-chelate surface function of the MNPs. 
The obtained magnetic nanobiocatalysts successfully catalyzed various 
biotransformations and gave high activity and excellent recyclability. These studies 
indicated the great potential of His-tag affinity as immobilization technique and MNPs 
with appropriate surface functions as immobilization carrier to fabricate active and 
stable magnetic nanobiocatalysts for various enzymatic biotransformations.  
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7.2 Recommendations 
In this thesis, magnetic nanobiocatalysts were fabricated through a simple method and 
their performance was explored in several biotransformations. Despite achieving 
excellent results by using the fabricated magnetic nanobiocatalysts, there is still room to 
seek ideal magnetic nanobiocatalysts employing affinity bonding immobilization or 
further study the applications of fabricated nanobiocatalysts.  
It is possible to introduce new metal-chelates on the MNPs. Hence, different metal ions 
with new chelating ligands can be tested. 
 For the metal ion, there are several candidates including Cu2+, Zn2+, etc. We 
demonstrated an example in Chapter 5 by using Co
2+
 as metal ion, which the 
immobilized enzyme (His-CysM) showed a higher stability during the recycling of 
the nanobiocatalyst compared with the Ni
2+
 as metal ion. 
 For the chelating ligand, there are many candidates that can be attached to these 
MNPs but one important criterion should be using a cheap compound for this 
purpose to lower the overall price of fabricated MNPs. To achieve that, 
functionalizing the MNPs with some of the readily available chelating ligands such 
as iminodiacetic acid might be appropriate. In addition, there are some potential 
chelating ligands that can be considered as good candidates for further 
investigations. For instance, L-3,4-dihydroxyphenylalanine (L-DOPA) is a cheap 
and abundant chemical, which can be oxidized to obtain a potential chelating ligand 
with three carboxylic acid groups. After that, this ligand can be attached to the 
epoxy (PGMA-MNPs) or aldehyde (GA-MNPs) via its amine group.   
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In this thesis, we have demonstrated the use of extracellular enzymes (His-TTL and 
His-CALB) from the cell culture supernatant as a simple method for the enzyme 
immobilization.  
 The simplicity and efficiency of this method light up a way to immobilize other 
extracellular enzymes and investigate their catalytic performances. This 
immobilization method would gain more attention if it was tested on the expensive 
and fragile enzymes such as some alcohol dehydrogenases. The intracellular 
enzyme requires cell disruption and prepurification, if the affinity immobilization is 
not applied, which fragile enzymes are less likely to be obtained in high yield and 
activity after these complex processes. Therefore, applying our method for these 
enzymes to prepare nanobiocatalysts may significantly simplify and enhance the 
yield of their immobilization procedure. 
Although the capability of His-TLL-MNPs for the enzymatic ring-opening 
polymerization was successfully demonstrated in this thesis, additional research can be 
conducted to discover more about its performance in enzymatic polymerization. 
 His-TLL-MNPs showed a relatively low activity for ROP of substituted lactones. 
These reactions can be studied more in-depth to enhance the polymer molecular 
weight and yield. The impact of the other common organic solvents such as 
diphenyl ether, dioaxne, etc., in the enzymatic polymerization probably can enhance 
these polymerizations. Also, some recent reports show that ionic liquids can alter 
the activity of the enzyme for the polymerization, which can be considered for the 
future studies. 
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 A further research can be conducted on the catalytic performance of the His-TLL-
MNPs for the polycondensation reactions. If the polycondensation was successful, 
it would emphasize the great potential of TLL as a catalyst for the enzymatic 
polymerizations in general.  
 The regio-, chemo-, and enantioselectivity of His-TLL-MNPs could be investigated 
by using appropriate monomers to synthesize well-defined polymers with new 
structure. 
MNPs are proved to be useful immobilization carriers for enzymatic ring-opening 
polymerization. This provides new opportunities to further study their applications for 
enzymatic polymerization. 
 Investigating the activity of the immobilized His-tagged CALB on the MNPs for 
the enzymatic polymerization can raise a fair comparison with Novozym 435 
(CALB immobilized on mesoporous carrier) as the most well-known immobilized 
enzyme reported for enzymatic polymerization. 
 Screening some new enzymes for enzymatic polymerization is also attractive 
approach for future works. Since using immobilized enzymes always have the 
priority for the enzymatic polymerization, the new enzymes specially lipases could 
be simply immobilized without prepurification and tested for the polymerization 
reactions. These enzymes may offer unique selectivities to synthesize novel 
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